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ABSTRACT 
 
C-terminal tail-anchored membrane proteins (TAs) are targeted post-
translationally to the endoplasmic reticulum (ER) in eukaryotic cells mainly 
through the Guided entry of tail-anchored protein (GET) pathway. Here we use 
biochemical and biophysical approaches to shed further mechanistic insight into 
how the central chaperone, the Get3 ATPase, is able to capture TA substrates in a 
privileged manner and provide unidirectional targeting to the ER.  
Specifically, we first show in Chapter 2 that Get3 dynamically samples open 
and closed conformations as a “protean clamp”. Binding of TA substrates induces 
Get3 to sample more open conformations that causes Get3 to dissociate from the 
cytosolic regulatory Get4/5 complex, hydrolyze ATP, and become primed to 
interact with the Get1/2 membrane receptors. Therefore, a TA substrate acts as the 
switch for unidirectional targeting, transitioning Get3 from a “TA-loading mode” 
to a “membrane targeting mode”. Next, in Chapter 3, we show that a small, 
conserved alpha-helical lid motif, known as α8, lining the substrate binding groove 
is necessary for Get3 to efficiently capture TA substrates in a privileged manner 
over competing off-pathway chaperones. 
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NOMENCLATURE 
 
µs-ALEX. Microsecond alternating laser excitation spectroscopy; solution-based 
single-molecule FRET technique that can determine E* and S values for individual 
fluorescent molecules. 
Acrylodan. Environmentally sensitive fluorophore. 
ADP. Adenosine diphosphate. 
ADP•AlF4. Adenosine diphosphate complexed with aluminum tetrafluoride; 
nonhydrolyzable analog of ATP. 
AMPPNP. Adenylyl-imidodiphosphate; nonhydrolyzable analog of ATP. 
ATP. Adenosine triphosphate. 
ATPase. ATP hydrolase; class of enzyme that catalyzes the hydrolysis of ATP to 
ADP and a free phosphate ion, which releases energy. 
ATTO 550. ATTO dye that can act as a FRET donor for ATTO 647N. 
ATTO 647N. ATTO dye that can act as a FRET acceptor for ATTO 550 or Cy3B. 
BAG6. An additional protein subunit found in the mammalian scaffolding complex 
that bridges SGTA and TRC40 (mammalian homologs of Sgt2 and Get3, 
respectively). 
BODIPY FL. Green fluorescence dye that can act as a FRET acceptor for coumarin 
or as a FRET donor for TMR. 
Bos1. Tail-anchored protein; SNARE protein. 
BSA. Bovine serum albumin; inert protein used as a surfactant for fluorescence 
experiments. 
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BVA. Burst variance analysis; used to determine whether heterogeneity in a FRET 
histogram is static or dynamic. 
CaM. Calmodulin; multifunctional protein; can bind and chaperone tail-anchored 
proteins. 
CAML. Mammalian counterpart of the Get2 membrane receptor. 
CD. Cytosolic domain. 
Coumarin. Blue fluorescence dye that can act as a FRET donor for BODIPY FL. 
cpSRP43. ATP-independent membrane protein chaperone found in the chloroplast 
of green plants; can also bind and chaperone tail-anchored proteins. 
CTD. C-terminal domain. 
Cy3B. Cyanine dye that can act as a FRET donor for ATTO 647N. 
DS. Dynamic score; used to quantify the dynamics of a FRET histogram. 
E*. Relative FRET efficiency. 
ER. Endoplasmic reticulum. 
FRET. Förster resonance energy transfer. 
GET pathway. Guided entry of tail-anchored protein pathway; one of the main 
pathways responsible for the targeting and insertion of tail-anchored proteins to the 
endoplasmic reticulum. 
Get1. One of the two protein subunits of the Get1/2 membrane receptor complex. 
Get2. One of the two protein subunits of the Get1/2 membrane receptor complex. 
Get3. ATPase; central chaperone of the GET pathway. 
xiv 
 
Get4. One of the two protein subunits of the Get4/5 scaffolding/regulatory complex; 
interacts with Get3. 
Get4/5N. Get4/5 complex consisting of a truncated Get5 that only contains its N-
terminal domain. 
Get5. One of the two protein subunits of the Get4/5 scaffolding/regulatory complex; 
interacts with Sgt2. 
Hsp70. Class of chaperones that are about 70 kDa in molecular weight. 
K-S test. Kolmogorov-Smirnov test; nonparametric statistical test. 
NMR. Nuclear magnetic resonance spectroscopy. 
NTD. N-terminal domain. 
PDB. Protein Data Bank. 
Privileged. Having special advantages. 
Protean. Ever-changing; dynamically fluctuating. 
S. Stoichiometry value; reports on the fraction of total fluorescence emitted from 
excitation at the donor excitation wavelength. 
Sbh1. Tail-anchored protein; Sec61β-homolog 1; component of the Sec61 
translocon. 
SD. Standard deviation. 
Sgt2. Cochaperone; receives TA proteins from Ssa1 and then delivers the TA protein 
to Get3 with assistance from the Get4/5 complex. 
SNARE proteins. Proteins of a protein complex involved in vesicle fusion. 
xv 
 
SPR. Surface plasmon resonance. 
SRP. Signal recognition particle; mediates co-translational targeting of nascent 
membrane and secretory proteins to either the ER in eukaryotes or the plasma 
membrane in bacteria. 
Ssa1. Highly abundant Hsp70 chaperone; mediates the initial capture of newly 
synthesized tail-anchored proteins from ribosomes. 
TA. Tail-anchored protein. 
Tail-anchored protein. Membrane protein with a single transmembrane domain at 
the extreme C-terminus. 
TMD. Transmembrane domain. 
TMR. Red fluorescence dye that can act as a FRET acceptor for BODIPY FL. 
TRC35. Mammalian homolog of Get4. 
TRC40. Mammalian homolog of Get3. 
UBL4A. Mammalian homolog of Get5. 
WDS. Weighted dynamic score; dynamic score that is normalized for differences in 
bin population. 
WRB. Mammalian homolog of Get1. 
yRM. Yeast rough microsomes. 
Zn2+. Zinc ion.
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C h a p t e r  1  
 
 
INTRODUCTION – THE GET PATHWAY FOR TARGETING OF 
TAIL-ANCHORED PROTEINS TO THE ENDOPLASMIC 
RETICULUM 
 
Adapted from: 
Chio, U.S., Cho, H., and Shan, S.-O. 2017. Mechanisms of Tail-Anchored 
Membrane Protein Targeting and Insertion. Annual Review of Cell and 
Developmental Biology 33: 417-438. doi: 10.1146/annurev-cellbio-100616-
060839. (Review) 
 
Membrane proteins account for ~35% of the proteins encoded by the genome. 
The proper functioning of biological membranes requires all newly synthesized 
membrane proteins to be localized to and inserted into the appropriate membrane 
destinations. The best-studied pathway for membrane protein targeting and insertion 
utilizes the signal recognition particle (SRP). SRP recognizes TMDs near the N-
terminus of nascent proteins and delivers them to translocation machineries on the 
eukaryotic endoplasmic reticulum (ER) during translation; this co-translational mode 
of targeting effectively minimizes the aggregation of membrane proteins in the 
cytosol (Akopian et al. 2013).  
Nevertheless, numerous membrane proteins cannot use SRP and must be 
targeted via post-translational pathways, the mechanisms of which are far less well-
understood. A salient example is the class of tail-anchored proteins (TAs), which 
contain a single TMD near the C-terminus. TAs compose 3–5% of the eukaryotic 
membrane proteome and mediate diverse cellular processes, including protein 
translocation across organelle membranes, vesicular transport, apoptosis, and protein 
quality control (Chartron et al. 2012a, Hegde & Keenan 2011). Because the C-
terminal TMDs of TAs are obscured by the ribosome during translation, it was 
predicted early on that these proteins would be targeted by post-translational 
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mechanisms (Kutay et al. 1993). In support of this hypothesis, synaptobrevin 2 
(Syb2), a tail-anchored SNARE protein, can be targeted to and inserted into the ER 
after release from the ribosome (Kutay et al. 1995). 
Much recent progress on TA biogenesis was driven by the discovery of the 
GET (Guided Entry of TA) pathway. The structure, dynamics, and interactions of 
GET components have been extensively characterized, providing the highest-
resolution understanding of a TA-targeting pathway thus far. 
1.1 SUMMARY OF THE PATHWAY 
Early studies showed that TA insertion into the ER is ATP-dependent and 
requires machineries distinct from those that mediate co-translational protein 
targeting (Kutay et al. 1995). Subsequently, cross-linking studies in reticulocyte 
lysate identified a 40-kDa ATPase, TRC40, as a key targeting factor for TAs 
(Favaloro et al. 2008, Stefanovic & Hegde 2007). The yeast homolog of TRC40, 
Get3, was genetically linked to two integral membrane proteins on the ER, Get1 and 
Get2 (Schuldiner et al. 2005), which were shown to form the receptor complex for 
Get3 (Schuldiner et al. 2008). An additional protein complex, comprising Get4 and 
Get5, was found to participate in the pathway on the basis of the genetic interactions 
of Get4 and Get5 with Get1, Get2, and Get3; reduced TA targeting in get5 lysates; 
and the physical association of the Get4/5 complex with Get3 (Jonikas et al. 2009). 
Biochemical reconstitutions showed that Get4/5 facilitates TA loading onto Get3 
from the upstream cochaperone Sgt2 (Wang et al. 2010) and TA proteins are first 
loaded onto the Hsp70 chaperone Ssa1 before transfer to Sgt2 (Cho and Shan 2018). 
Homologs or functional orthologs of all components of the yeast GET pathway have 
been identified in mammalian cells (Table 1.1) (Colombo et al. 2016; Mock et al. 
2015; Vilardi et al. 2011, 2014; Xu et al. 2012; Yamamoto & Sakisaka 2012). 
Collectively, these works define a conserved pathway in eukaryotic cells that 
mediates the targeted delivery and insertion of TAs into the ER. 
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Cell type 
Upstream 
cochaperone 
 
Scaffolding complex 
Cytosolic 
ATPase 
Membrane 
receptors 
Yeast Sgt2 Get4/5 Get3 Get1/2 
Mammal SGTA TRC35/UBL4A/BAG6 TRC40 WRB/CAML 
 
Table 1.1: Components of the GET pathway in yeast and mammalian cells. 
 
This early work, together with subsequent mechanistic studies, defined the 
major molecular events in the GET pathway (Figure 1.1). After a nascent TA is 
synthesized and released from the ribosome, it is captured by Sgt2 through transfer 
from the Hsp70 chaperone Ssa1 (step 1). The Get4/5 complex, via its abilities to 
bridge between Sgt2 and Get3 and to regulate the conformation of Get3, stimulates 
the transfer of TA substrate from Sgt2 to ATP-bound Get3 (step 2). The Get3•TA 
complex dissociates from Get4/5, and the TA substrate stimulates ATP hydrolysis on 
Get3 (step 3). The Get3•TA complex then engages the Get1/2 receptor complex at 
the ER membrane (step 4), where Get1/2 releases TA from Get3 and facilitates TA 
insertion into the membrane (step 5). Finally, Get3 is released from Get1 and is 
returned to the cytosol through binding of ATP and Get4/5 (step 6). Our 
understanding of the molecular mechanisms of these events prior to the work 
presented in this thesis is further discussed below. 
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Figure 1.1: Major steps in the yeast GET pathway. (1) A nascent tail-anchored 
protein (TA) is captured by Sgt2 through Ssa1 after translation by the ribosome. 
Structure 1 (PDB 3SZ7) shows the Sgt2 tetratricopeptide repeat (TPR) domain, 
which binds various chaperones. (2) Sgt2 transfers the TA to Get3, a process 
stimulated by the Get4/5 complex. Structure 2 (PDB 2LXC) shows the N-terminal 
domain of Sgt2 bound to the ubiquitin-like (UBL) domain of Get5. (3) The Get3•TA 
complex dissociates from Get4/5, and ATP hydrolysis is activated. (4) The Get2 
subunit in the Get1/2 receptor captures the Get3•TA complex. (5) Following ADP 
release, Get1 interacts with and disassembles the Get3•TA complex, and the TA is 
inserted into the membrane through an unknown mechanism. (6) ATP and Get4/5 
together drive the release of Get3 from Get1, recycling Get3 for additional rounds of 
targeting. Structure 3 (PDB 2LNZ) shows the Get5 homodimerization domain. TMD 
denotes transmembrane domain. 
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1.2 STRUCTURE AND FUNCTION OF SGT2 
The most upstream factor identified thus far in the GET pathway is the Hsp70 
chaperone Ssa1, which captures TAs after their translation. Ssa1 then transfers TAs 
to the cochaperone Sgt2 (Cho & Shan 2018). Sgt2 contains multiple protein 
interaction domains: an N-terminal homodimerization domain (NTD) that binds 
Get5, a tetratricopeptide repeat (TPR) domain that interacts with chaperones, and a 
glutamine- and methionine-rich C-terminal domain (CTD) (Figure 1.1). 
Immunoprecipitation experiments demonstrated that the Sgt2 CTD forms the 
substrate-binding site that selectively captures the TMDs of ER-destined TAs (Rao 
et al. 2016, Wang et al. 2010). The molecular basis of this recognition is unclear but 
was speculated to be analogous to how the methionine-rich domain of SRP 
recognizes hydrophobic signal sequences in substrate proteins (Wang et al. 2010). 
As the individual domains of Sgt2 are connected by flexible linkers, the relative 
positions of these domains have not been defined. Small-angle X-ray scattering 
(SAXS) data suggested that the global conformation of Sgt2 is extended but likely 
flexible (Chartron et al. 2011), which raises possibilities of regulation by its diverse 
binding partners. 
The Sgt2 NTD is both a homodimerization domain and interaction platform 
for the ubiquitin-like (UBL) domain of Get5, linking this cochaperone with the rest 
of the GET pathway (Chang et al. 2010, Chartron et al. 2010, Liou et al. 2007, Wang 
et al. 2010). Nuclear magnetic resonance (NMR) and crystallographic analyses of the 
Saccharomyces cerevisiae Sgt2 NTD bound to the Get5 UBL domain elucidated the 
molecular details of their interaction (Figure 1.1, Structure 2) (Chartron et al. 2012b, 
Simon et al. 2013, Tung et al. 2013). The Sgt2 homodimer interface is formed by a 
four-helix bundle, which is contributed by two N-terminal helices from each Sgt2 
NTD and is stabilized by hydrophobic interactions. In contrast, the interaction of the 
Sgt2 NTD with the Get5 UBL domain is electrostatically driven. Conserved residues 
on the second helices of the Sgt2 NTD form an acidic surface that interacts with 
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conserved basic and hydrophobic residues on a single Get5 UBL domain via charge 
and shape complementarity (Figure 1.1, Structure 2). The Sgt2-Get5 interaction is 
stable but occurs with fast association and dissociation kinetics (Chartron et al. 
2012b, Simon et al. 2013), which may allow Get4/5 to rapidly sample Sgt2 
molecules. 
1.3 GET4/5: A SCAFFOLD THAT BRIDGES SGT2 AND GET3 
After capture by Sgt2, the TA substrate is transferred to Get3 in a Get4/5-
dependent process (Wang et al. 2010). Get5 is a modular protein composed of an 
NTD that interacts with Get4, a UBL domain that binds the Sgt2 NTD as described 
above, and a CTD that mediates homodimerization (Figure 1.1, Structure 3) 
(Chartron et al. 2010). A minimal Get4/5N complex, formed between Get4 and the 
Get5 NTD, was sufficient to recognize Get3 in a specific conformation and 
nucleotide state (Gristick et al. 2014, 2015) and was hence subjected to extensive 
biochemical and structural studies. Get4 forms an α2-solenoid fold composed of 14 
right-handed helical coils (Bozkurt et al. 2010, Chang et al. 2010, Chartron et al. 
2010). The N-terminal helix of Get5 docks into a hydrophobic groove formed by 
helices α12 and α13 and the β-tongue of Get4, forming an extremely stable Get4-
Get5 interface (Chang et al. 2010, Chartron et al. 2010). On the other side of the 
Get4/5N complex, the N-terminal helices of Get4 provide a combination of acidic 
and hydrophobic residues to mediate interaction with Get3 (further discussed in the 
section titled The Get3 ATPase Cycle, below). 
Multiple groups have reconstituted Get4/5-mediated stimulation of TA 
transfer from Sgt2 to Get3 (Mateja et al. 2015, Rao et al. 2016, Wang et al. 2010). 
Nevertheless, the precise mechanism(s) underlying the stimulatory effect of Get4/5 
is not completely understood. By bringing Sgt2 and Get3 into close proximity, Get4/5 
could enable a facile route for relay of a TA substrate while minimizing cytosolic 
exposure of the substrate TMD (Figure 1.1). In support of this model, the TA is 
protected from external traps during the transfer, and mutations disrupting the Sgt2-
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Get5 interaction resulted in significantly less TA transfer and less insertion-
competent Get3•TA complexes (Mateja et al. 2015, Shao et al. 2017). As discussed 
below in the section titled The Get3 ATPase Cycle, the Get4/5 complex also regulates 
the conformation of the Get3 ATPase, which could further promote substrate capture 
by Get3. It is also plausible that Get5 induces rearrangements in Sgt2 that facilitate 
TA release. The relative contributions of these mechanisms to the substrate handover 
event remain to be defined. 
The Get5 CTD forms a stable dimer interface mediated by hydrophobic 
interactions (Chartron et al. 2012c). SAXS data also showed that Get4 and Get5 form 
an elongated heterotetramer (2:2) spanning 240 Å (see architecture of the 
heterotetrameric complete Get4/5 complex in Figure 1.1) (Chartron et al. 2010). 
Nevertheless, the functional relevance of Get5 homodimerization is unclear. The 
residues that mediate Get5 homodimerization are not conserved in its mammalian 
homolog. Furthermore, there appears to be an intriguing asymmetry in the Get4/5 
complex such that only one copy of Get4 in this heterotetramer binds Get3 at 
physiological protein concentrations (Gristick et al. 2015, Mateja et al. 2015). The 
mechanism of this asymmetric interaction and the evolutionary relevance of the Get5 
homodimerization domain remain to be determined. 
1.4 THE GET3 ATPASE CYCLE: NUCLEOTIDE-, EFFECTOR-, 
AND SUBSTRATE-INDUCED CONFORMATIONAL 
CHANGES DRIVE THE TARGETING PATHWAY 
Central to the GET pathway is the ATPase Get3, which uses its ATPase cycle 
to capture and deliver TAs to the ER membrane (Favaloro et al. 2010, Stefanovic & 
Hegde 2007). Early crystallographic work showed that Get3 undergoes ATP-
dependent rearrangements that can be coupled to substrate binding (Figure 1.2, step 
1). Get3 is an obligate homodimer bridged by a tightly coordinated Zn2+ ion. Each 
Get3 subunit contains a nucleotide hydrolase domain structurally and functionally 
coupled to a helical domain. Apo-Get3 crystallizes in an open conformation, in which 
the two helical domains are apart (Figure 1.2, Structure 1). In contrast, non-
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hydrolyzable ATP analogs induce readjustments at the dimer interface that bring the 
helical domains closer to one another (Figure 1.2, Structure 2) (Bozkurt et al. 2009, 
Hu et al. 2009, Mateja et al. 2009, Suloway et al. 2009). Importantly, closing of Get3 
brings together conserved hydrophobic residues in the helical domains to form a 
hydrophobic groove that provides the binding site for the TA TMD (Mateja et al. 
2015). Nevertheless, Get3 has been observed in a variety of conformations that differ 
in the degree of opening or closing, suggesting the presence of more than two defined 
states. Furthermore, molecular dynamics simulations suggest that Get3 dynamically 
samples multiple conformations (wide-open, open, semi-open, semi-closed, and 
closed) in different nucleotide states (Wereszczynski & McCammon 2012). The 
number of conformational states in Get3 and how they are regulated by nucleotides 
remain to be defined. 
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Figure 1.2: The Get3 ATPase cycle is driven by nucleotides, effectors, and tail-
anchored protein (TA) substrates. Structure 1 shows apo-Get3 in an open 
conformation (PDB 3H84), although whether this species exists in vivo is unclear. 
(1) ATP binding induces Get3 into a closed conformation (Structure 2; PDB 2WOJ). 
(2) Get4/5 preferentially binds closed Get3 and inhibits its ATPase activity, 
generating an occluded state (Structure 3; PDB 4PWX). (3) TA binding induces Get3 
into an activated state, and Get3 dissociates from Get4/5. The crystal structure of 
Get3 bound with a transmembrane domain (TMD) peptide is shown in Structure 4 
(PDB 4XTR), although the structural basis for the TA-induced activation of Get3 is 
unclear. (4) Activated Get3 hydrolyzes ATP, and the ADP-bound Get3•TA complex 
can bind Get2. (5) ADP release induces additional rearrangements in the Get3•TA 
complex, which enable it to interact with Get1. (6) The strong preference of Get1 for 
a wide-open Get3 (Structure 5; PDB 3SJB) drives the release of TA from Get3. CD 
denotes cytosolic domain. The two subunits in the Get3 homodimer are in blue and 
tan in all structures. 
Indeed, subsequent biochemical, enzymatic, and structural analyses 
uncovered additional conformational states in Get3 that are regulated by the TA 
substrate and other GET components. A major regulator is the Get4/5 complex. 
Pulldown (Chartron et al. 2010, Gristick et al. 2014) and fluorescence (Rome et al. 
2014) studies showed that Get4 preferentially binds ATP-bound Get3, and 
reciprocally, Get4/5 stabilizes ATP binding to Get3 (Rome et al. 2013). As ATP 
stabilizes closed Get3, the synergy between ATP and Get4/5 in binding Get3 strongly 
suggests that Get4/5 also stabilizes Get3 in a closed conformation. In contrast, Get4/5 
inhibits the ability of Get3 to hydrolyze ATP (Rome et al. 2013), suggesting that the 
global closing of Get3 can be uncoupled from catalytic activation at the ATPase site. 
This Get4/5-induced new state of Get3, termed occluded, was visualized 
crystallographically using Get4/5N bound to a hydrolysis-deficient mutant of Get3, 
Get3 (D57V), loaded with ATP (Gristick et al. 2014). A single Get4 molecule bridges 
the Get3 dimer interface and interacts with both subunits of Get3 (Figure 1.2, 
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Structure 3). The interaction with one Get3 subunit consists of both electrostatic and 
hydrophobic contacts, generating an anchoring interface for high-affinity binding of 
Get4/5 to ATP-bound Get3 (Gristick et al. 2014). Additional residues in Get4 
establish a regulatory interface with the other Get3 subunit, at which a putative salt 
bridge between Get3 K69 and Get4 D74 is critical for ATPase inhibition (Gristick et 
al. 2014). Together, these results show that Get4/5 primes Get3 into the optimal 
conformation and nucleotide state for capturing the TA substrate. 
In contrast to Get4/5, a TA substrate induces a rapid round of ATP hydrolysis 
on Get3 (Rome et al. 2013). This observation led to the proposal that the TA substrate 
induces Get3 into an activated conformation and leads to the ATP hydrolysis event 
after TA loading on Get3 (Figure 1.2, steps 3 and 4). Upon TA loading, the 
interaction of Get3 with Get4/5 is weakened at least tenfold in the presence of ATP, 
and the interaction becomes undetectable with a nucleotide-free Get3•TA complex 
(Rome et al. 2014). These findings suggest that the TA substrate also helps drive the 
dissociation of Get3 from Get4/5. Finally, the TA substrate significantly slows 
nucleotide exchange on Get3. Compared to free Get3, ADP release from the 
Get3•TA complex is 200-fold slower, and ATP rebinding to the Get3•TA complex 
is 10,000-fold slower and rate limited by a conformational change at physiological 
ATP concentrations (Rome et al. 2013). Slower nucleotide exchange provides 
extended time windows of ∼14 and ∼12 s for Get3•TA complexes in the ADP-bound 
and nucleotide-free states, respectively, during which these complexes can interact 
with the Get1/2 receptor complex (see the section titled The Get1/2 Membrane 
Receptor Complex Remodels the Targeting Complex, below). 
1.5 THE GET1/2 MEMBRANE RECEPTOR COMPLEX 
REMODELS THE TARGETING COMPLEX 
Get1/2 provides the receptor complex for the Get3•TA complex at the ER 
membrane (Schuldiner et al. 2008). Biochemical reconstitution with proteoliposomes 
validated that these two proteins (and their mammalian homologs) are necessary and 
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sufficient for TA targeting and insertion (Mariappan et al. 2011, Vilardi et al. 2014, 
Wang et al. 2011, Yamamoto & Sakisaka 2012). Both Get1 and Get2 contain three 
predicted TMDs via which they assemble into a complex (Mariappan et al. 2011, 
Wang et al. 2014). Both proteins also contain large cytosolic domains (CDs) (the N-
terminal CD in Get2 and the TM1-TM2 loop in Get1) that interact with Get3. 
Get2CD contains two amphiphilic helices connected by a glycine linker, and helix 
α1 electrostatically contacts one of the subunits in the Get3 dimer via conserved basic 
residues in the 14RERR motif (Mariappan et al. 2011, Stefer et al. 2011, Wang et al. 
2011). Whereas the Get2CD co-crystallized with closed, nucleotide-bound Get3 
(Mariappan et al. 2011, Stefer et al. 2011), the Get1CD co-crystallized with apo-Get3 
in the most open conformation observed thus far (Figure 1.2, Structure 5). The 
Get1CD consists of two helices that form a coiled coil, which inserts like a wedge 
into the Get3 dimer interface and contacts both Get3 subunits in the dimer (Kubota 
et al. 2012, Mariappan et al. 2011, Stefer et al. 2011). Contacts with one Get3 subunit 
occur at its nucleotide-binding domain, where an extensive interface is formed by 
both aromatic and charged residues. Contacts with the other Get3 subunit are smaller 
and involve helix α4 in its helical domain. Finally, Get1 and Get2 share overlapping 
interaction surfaces, notably the 303DELYED motif on helix α11, on Get3 (Mariappan 
et al. 2011, Stefer et al. 2011). Both receptor subunits also share overlapping binding 
sites on Get3 with Get4/5 (Gristick et al. 2014). Thus, these upstream and 
downstream GET proteins compete for interaction with Get3 during the targeting 
cycle. 
These structural data, together with the following observations, strongly 
suggest that the Get3•TA complex is first captured by Get2 and then transferred to 
Get1. Get2 contains a >100-amino-acid linker that connects its Get3-binding helices 
to its TMDs, which may allow Get2 to search for Get3•TA complexes further away 
from the ER. Surface plasmon resonance (SPR) and fluorescence analyses show that 
the Get2CD can bind Get3 and Get3•TA complexes in nucleotide-bound states, 
whereas the Get1CD binds only the nucleotide-free Get3•TA complex and strongly 
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prefers apo-Get3 in which the TA-binding groove is disrupted (Mariappan et al. 
2011, Rome et al. 2014, Stefer et al. 2011). Finally, high concentrations of the 
Get1CD can displace TA from Get3, whereas the Get2CD cannot (Mariappan et al. 
2011, Wang et al. 2011). Together, these results support a model in which the 
Get3•TA complex bound with ADP is initially recruited to the membrane by Get2; 
upon ADP release, the Get1CD initiates interaction with and remodels the Get3•TA 
complex, leading to the release of TA from Get3 and to its insertion into the ER 
membrane (Figure 1.1, steps 4 and 5, and Figure 1.2, steps 5 and 6). 
These data also predict that a stable complex between the Get1CD and apo-
Get3 accumulates at the ER membrane at the end of the targeting cycle (Figure 1.1, 
end of step 5). The tip of Get1 remodels both switch I and switch II loops at the Get3 
ATPase site, inducing these loops into a conformation incompatible with nucleotide 
binding (Kubota et al. 2012, Mariappan et al. 2011, Stefer et al. 2011). Consistent 
with the structures, SPR and fluorescence measurements showed that ATP and the 
Get1CD strongly antagonize one another for binding to Get3 (Kubota et al. 2012, 
Mariappan et al. 2011, Rome et al. 2014, Stefer et al. 2011). Furthermore, addition 
of ATP accelerated the release of Get3 from the Get1CD and vice versa, suggesting 
a release mechanism involving active displacement (Kubota et al. 2012, Rome et al. 
2014). Finally, with full-length Get1/2 proteoliposomes or ER microsomes, Get4/5 
was also needed to promote the facile release of Get3 from the membrane (Rome et 
al. 2014). Thus, the recycling of Get3 in the GET pathway is an elaborate event driven 
by both ATP and Get4/5 (Figure 1.1, step 6). 
Despite extensive progress, multiple questions remain for the GET pathway. 
First, the structural basis for the TA-induced changes in Get3 activity is unclear. 
Although a co-crystal structure of Get3 (D57N) bound to a TMD peptide (Mateja et 
al. 2015) is available, the conformation of Get3 in this structure is similar to the 
conformations in the Get3·Get4/5 complex and in ADP•AlF4-bound Get3. The 
structure, dynamics, and mechanism of regulation of the Get3•TA complex remain 
to be elucidated at the molecular level (Figure 1.2, question marks) and are the 
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subjects of the work presented in Chapters 2 and 3 of this thesis. In addition, the 
structures of important intermediates in the pathway, such as Get2 and/or Get1 bound 
to the Get3•TA complex, are still unavailable. Whether Get2 acts passively to bring 
the Get3•TA complex to Get1 or plays a more active role is unclear and remains to 
be determined. 
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C h a p t e r  2  
 
 
A PROTEAN CLAMP GUIDES MEMBRANE TARGETING  
OF TAIL-ANCHORED PROTEINS 
 
Adapted from: 
Chio, U.S., Chung, S., Weiss, S., and Shan, S.-O. 2017. A protean clamp guides 
membrane targeting of tail-anchored proteins. Proceedings of the National 
Academy of Sciences U. S. A. 114(41): E8585-E8594. doi: 
10.1073/pnas.1708731114. 
 
Proper localization of proteins to target membranes is a fundamental cellular 
process. How the nature and dynamics of the targeting complex help guide substrate 
proteins to the target membrane is not understood for most pathways. In this chapter, 
we address this question for the conserved ATPase Get3, which targets the essential 
class of tail-anchored proteins (TAs) to the endoplasmic reticulum (ER). Single-
molecule fluorescence spectroscopy showed that, contrary to previous models of a 
static closed Get3•TA complex, Get3 samples open conformations on the sub-
millisecond timescale upon TA binding, generating a fluctuating “protean clamp” 
that stably traps the substrate. Point mutations at the ATPase site bias Get3 toward 
closed conformations, uncouple TA binding from induced Get3•Get4/5 disassembly, 
and inhibit the ER targeting of the Get3•TA complex. These results demonstrate an 
essential role of substrate-induced Get3 dynamics in driving TA targeting to the 
membrane, and reveal a tightly coupled channel of communication between the TA-
binding site, ATPase site, and effector interaction surfaces of Get3. Our results 
provide a precedent for large-scale dynamics in a substrate-bound chaperone, which 
provides an effective mechanism to retain substrate proteins with high affinity while 
also generating functional switches to drive vectorial cellular processes. 
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2.1 INTRODUCTION 
Over 35% of proteins need to be localized to the correct cellular destinations 
after their initial synthesis in the cytosol. These protein-targeting processes are 
essential for the establishment and maintenance of compartmentalization in all cells 
and pose complex mechanistic challenges to targeting machineries. To minimize 
improper exposure of substrate proteins in the cytosol, targeting factors must bind 
substrate proteins with high stability. This requirement is especially stringent during 
the targeting of integral membrane proteins, whose high aggregation propensity in 
the cytosol and other aqueous cellular environments demands that targeting factors 
also serve as effective chaperones to protect substrates from aggregation. Further, to 
minimize futile cycling of targeting factors, loading of substrates on the targeting 
factor must be tightly coupled to their delivery to membrane receptor sites. Finally, 
once at the target membrane, the targeting machinery must readily switch to a low-
affinity state to release substrate proteins to receptor complexes, translocases, or the 
phospholipid bilayer. With a few exceptions (Akopian et al. 2013, Tsirigotaki et al. 
2017), the nature and dynamics of protein targeting complexes and how their 
biophysical properties help meet these complex functional demands are not well 
understood, especially for post-translational protein targeting pathways. 
The targeting of tail-anchored proteins (TAs) provides an excellent system to 
address these questions. TAs, defined by a single transmembrane domain (TMD) 
near the C terminus, comprise up to 5% of the eukaryotic membrane proteome and 
mediate diverse key cellular functions, including protein translocation across 
multiple organelle membranes, vesicular fusion, protein quality control, and 
apoptosis (Borgese & Fasana 2011). In eukaryotic cells, TAs are targeted to the 
endoplasmic reticulum (ER) by the conserved guided entry of tail-anchored protein 
(GET) pathway, in which the Get3 ATPase captures TAs with help of the cytosolic 
Get4/5 complex and then delivers TAs to the Get1/2 receptor complex at the ER 
membrane (Chartron et al. 2012a, Denic et al. 2013, Hegde & Keenan 2011). During 
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the targeting cycle, Get3 undergoes extensive changes in conformation and activity 
in response to nucleotides, effector proteins, and the TA substrate (Figure 2.1). In the 
cytosol, ATP binding drives the Get3 homodimer from an open conformation, in 
which the helical domains of the two Get3 subunits are apart, to a closed 
conformation in which the helical domains are close together (Bozkurt et al. 2009, 
Mateja et al. 2009) (Figure 2.2). Closed ATP•Get3 is preferentially bound by the 
Get4/5 complex (Gristick et al. 2014, Rome et al. 2014), which bridges between Get3 
and the upstream cochaperone Sgt2 and stimulates TA transfer from Sgt2 onto Get3 
(Mateja et al. 2015, Rao et al. 2016, Wang et al. 2011). After dissociation from 
Get4/5, the Get3•TA complex hydrolyzes ATP and interacts with the Get1/2 
membrane receptors (Rome et al. 2013, 2014). Get1 drives Get3 into an open 
conformation, enabling TA release and insertion into the membrane (Kubota et al. 
2012, Mariappan et al. 2011, Stefer et al. 2011, Wang et al. 2011). (See Chapter 1 for 
a more detailed review) 
 
 
Figure 2.1: Current model for Get3 conformations throughout the GET 
pathway. Question marks (“?”) highlight unresolved questions. 
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Figure 2.2: Structures of open and closed Get3. Approximate positions of donor 
and acceptor dyes (green and red stars, respectively) in the structures of open Get3 
(left; PDB 3H84) and closed Get3 (right; PDB 2WOJ). The bound ADP•AlF4- in 
closed Get3 is in space-fill. 
Despite these advances, the conformation and dynamics of the Get3•TA 
complex during targeting remain an outstanding question (Chartron et al. 2012a, 
Denic et al. 2013, Shan 2016). Crystallographic analyses showed that Get3 “closing” 
generates a contiguous hydrophobic groove in its helical domains (Bozkurt et al. 
2009, Mateja et al. 2009), which provides a binding site for the TMD of TA 
substrates. The co-crystal structure of Get3 bound with a TA-TMD (Mateja et al. 
2015) also shows a closed Get3 similar to that in the ATP•Get3•Get4/5 complex 
(Gristick et al. 2014). It was proposed that closed Get3 stably binds TA substrates 
and protects the TMD from exposure to the cytosol (Mateja et al. 2009, 2015). 
However, an exclusively closed Get3•TA complex poses a fundamental dilemma for 
targeting (Figure 2.1, “?”). Based on thermodynamic coupling, if both Get4/5 and 
TA prefer closed Get3, TA loading would strengthen the Get3–Get4/5 interaction. In 
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contrast, multiple downstream events in the pathway require Get3 to dissociate from 
Get4/5 after TA loading. These include the interaction of Get3 with Get1/2, whose 
binding sites on Get3 overlap with Get4/5 (Gristick et al. 2014, Kubota et al. 2012, 
Mariappan et al. 2011, Rome et al. 2014, Stefer et al. 2011), and ATP hydrolysis by 
Get3, which is inhibited by Get4/5 (Rome et al. 2013). These considerations predict 
that substrate-loaded Get3 must adopt conformation(s) that are different from the 
highly closed structures observed previously. Indeed, biochemical studies showed 
that a TA substrate destabilizes the interaction of Get3 with Get4/5 and activates the 
Get3 ATPase activity (Rome et al. 2013, 2014), implying that the substrate induces 
Get3 into distinct conformational state(s). 
The GET pathway provides a salient example of the complex functional 
demands on the targeting machinery during a targeting cycle, as well as the 
conceptual and experimental challenges in understanding how these demands are 
met. The model of an exclusively closed Get3•TA complex also exemplifies the 
typical view of targeting complexes as static structures, wherein substrates fit into 
well-defined grooves or pockets in conformationally closed targeting factors or 
chaperones. Recent NMR studies began to challenge this view, demonstrating that 
client proteins populate a dynamic ensemble of conformational states and transit 
between multiple short-lived interaction sites when bound to chaperones such as Skp, 
SurA, and Spy during trafficking through the bacterial periplasm (Burmann et al. 
2013, He et al. 2016, Thoma et al. 2015). Nevertheless, the nature and dynamics of 
the targeting factors/chaperones in these complexes, and how these properties help 
guide substrate proteins to the target membrane, have not been addressed. 
To address these questions, we studied the conformation and dynamics of 
Get3 using single-molecule spectroscopy with microsecond time resolution. These 
analyses show that, contrary to previous models, the TA substrate destabilizes a 
closed Get3 and induces the ATPase to sample open conformations on the sub-
millisecond timescale. Biochemical analyses demonstrate that these changes in the 
TA-binding domain are transmitted via the ATPase active site to drive the 
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dissociation of Get3 from Get4/5, and are essential for the targeting of TA substrates 
to the Get1/2 receptors at the ER membrane. These results provide a unifying model 
to explain how the TA substrate drives the switch of Get3 from a substrate-loading 
mode to a membrane-targeting mode. Moreover, they demonstrate how rapid protein 
motions allow a targeting factor/chaperone to stably retain its substrate protein while 
undergoing changes in structure and function to vectorially drive a cellular pathway. 
2.2 RESULTS 
Diffusion-based single-molecule spectroscopy detects global structure and 
dynamics of Get3 
To measure the global conformational changes of Get3, we used diffusion-
based single-molecule Förster resonance energy transfer (FRET) between donor 
(Cy3B) and acceptor (ATTO 647N) dyes site-specifically incorporated in the two 
subunits of the Get3 dimer (Figure 2.2). Fluorophores were incorporated at a 
nonconserved loop in the Get3 helical domain, and labeling does not affect the 
activity of Get3 (Rao et al. 2016). We used confocal microscopy with alternating 
laser excitation with microsecond time resolution (μs-ALEX) to detect and quantify 
the fluorescence of single molecules transiting through a femtoliter-scale observation 
volume, and extracted relative FRET efficiencies (E*) for individual molecules 
(Kapanidis et al. 2005) (Figure 2.3). The distances between the dye pair are estimated 
to be ∼75 Å and ∼30 Å in open and closed Get3, respectively (Figure 2.2). Thus, a 
significant difference in FRET between the open and closed conformations of Get3 
is expected for this dye pair, allowing us to monitor transitions along these states. 
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Figure 2.3: Monitoring Get3 conformational changes using µs-ALEX. (A) 
Schematic depiction of the µs-ALEX method. Donor and acceptor dyes labeled on 
Get3 were alternatively excited as they diffused through a confocal volume. Both the 
donor-to-acceptor S and relative E* were determined for individual Get3 molecules, 
allowing for optical purification of doubly labeled Get3 (S ~ 0.5; cyan bracket) and 
differentiation of Get3 conformations displaying different E* values. FRET 
histograms were obtained by 1D projection of 2D E*-S histograms onto the E* axis 
after isolating doubly-labeled Get3. (B) Representative E*-S histogram of 
stochastically double-labeled apo-Get3 showing both single- and doubly-labeled 
Get3 populations. (C) Representative E*-S plot of apo-Get3 after a dual-channel 
burst search to isolate doubly-labeled Get3.  
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We first used μs-ALEX to visualize the conformations of Get3 under well-
established conditions. Apo-Get3 displayed a broad FRET distribution, with E* 
maxima ranging from 0.5–0.7 (Figure 2.4 and reproducibility of data in Figure 2.5). 
The distribution for ADP-bound Get3 was also broad but peaked at higher FRET 
(Figure 2.4B). When Get3 was bound to the non-hydrolyzable ATP analog adenosine 
5′-(β,γ-imido)triphosphate (AMPPNP), the FRET distribution was narrower and 
peaked at an E* of ∼0.8 (Figure 2.4C). In contrast, the cytosolic domain of Get1 
(Get1CD) shifted the distribution to lower FRET (peak E* of ∼0.3; Figure 2.4D). 
These data agree with previous work showing that ATP induces Get3 to closed 
conformations (Bozkurt et al. 2009, Mateja et al. 2009), whereas Get1CD induces 
the open state of Get3 (Kubota et al. 2012, Mariappan et al. 2011, Stefer et al. 2011). 
To exclude photophysical artifacts, we repeated these measurements using another 
FRET pair, ATTO 550 and ATTO 647N, which yielded the same nucleotide and 
Get1CD-induced changes in FRET distributions (Figure 2.6). In addition, the 
presence of various ligands and interaction partners did not affect the dye 
photophysics in a way that would alter the FRET distributions (Figure 2.7). We also 
confirmed that Get3 dimers do not exchange subunits during measurements (Figure 
2.8). Thus, our labeling strategy coupled with μs-ALEX can monitor the 
conformational transitions of Get3. 
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Figure 2.4: Direct observation of Get3 conformational changes using µs-ALEX. 
(A–D) FRET histograms for Get3 in apo-, ADP-, AMPPNP-, and Get1CD-bound 
states, respectively. Lighter shaded molecules depict alternative conformations 
sampled by Get3. The letter “n” denotes the number of observed doubly-labeled Get3 
used to generate each FRET histogram. (E–H) BVAs for apo-, ADP-, AMPPNP-, 
and Get1CD-bound Get3, respectively. The red curves indicate the expected SD for 
shot-noise-limited E* (static limit). Triangles denote the mean SD for individual 
FRET bins used to calculate the dynamic score (DS) and weighted dynamic score 
(WDS) (see Chapter 2.4, µs-ALEX data analysis). 
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Figure 2.5: Replicates of the FRET histograms for apo-Get3. The orange outline 
shows the histogram generated by combining all of the data. 
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Figure 2.6: Get3 FRET histograms with ATTO 550. (A–D) FRET histograms of 
Get3 in the apo-, ADP-, ATP-, and Get1CD-bound states, respectively, for Get3 
doubly-labeled with ATTO 550 and ATTO 647N. All of the FRET histograms are 
shifted to higher E* compared with Cy3B- and ATTO 647N-labeled Get3, as 
expected from the longer Förster radius of the ATTO 550-ATTO 647N pair. 
Nevertheless, the ligand-induced changes in the FRET histogram follow the same 
trends as those measured with the Cy3B-ATTO 647N pair. The letter “n” denotes the 
number of observed doubly-labeled molecules used to generate each FRET 
histogram. 
 
Figure 2.7: Controls for dye photophysics in µs-ALEX measurements of Get3. 
(A and B) Effects of ligands on the steady-state fluorescence spectra of Cy3B-labeled 
Get3 and ATTO 647N-labeled Get3, respectively, measured using a Fluorolog 3-22 
spectrofluorometer. Saturating amounts of each interaction partner (2 mM ATP, 4 
mM ADP, 10 µM Get1CD, 4 µM Get4/5) were used. Most interaction partners did 
not significantly affect Cy3B or ATTO 647N fluorescence. ATP modestly reduced 
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the fluorescence for both Cy3B and ATTO 647N, which should not significantly 
affect calculated FRET. arb., arbitrary. (C) TA substrate did not significantly affect 
the peak photon rate for both Cy3B and ATTO 647N, determined using the µs-ALEX 
setup for singly-labeled Get3. This suggests that the TA substrate does not affect the 
photophysics of the FRET pair on Get3. 
 
Figure 2.8: Controls for monomer exchange in µs-ALEX measurements of Get3. 
(A and B) Representative E*-S plots for a mixture of donor-only and acceptor-only 
labeled Get3 before (A) and after (B) a dual-channel burst search. The absence of 
substantial colocalization of the donor and acceptor fluorophores indicates no 
significant exchange of Get3 subunits on our experimental timescale. 
The FRET distributions of Get3 are broad, suggesting conformational 
heterogeneity. To distinguish whether this arises from the coexistence of multiple 
static structures or from dynamic conformational sampling, we performed burst 
variance analysis (BVA), which detects dynamics by comparing the SD of E* over 
time with the SD expected from shot noise (Torella et al. 2011). If the FRET 
distribution arises solely from static species, the SD is limited by shot noise and 
would lie on the static limit curve (Figure 2.4 E–H, red lines). In contrast, if multiple 
conformations interconvert on the sub-millisecond or faster timescale, the observed 
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SD would be higher than the static limit. Apo- and ADP-bound Get3 displayed 
substantially higher SDs than the static limit, especially for molecules that exhibit 
intermediate E* values (Figure 2.4 E and F). In contrast, the SDs for AMPPNP- and 
Get1CD-bound Get3 are close to the static limit, especially for molecules at the peak 
E* values (Figure 2.4 G and H). Thus, apo-Get3 and ADP-bound Get3 sample a 
range of conformations on the sub-millisecond timescale, as suggested by molecular 
dynamics simulations (Wereszczynski & McCammon 2012), and the peak E* values 
of 0.4–0.6 exhibited by apo-Get3 arise from conformational averaging between states 
with higher and lower FRET. Further, different interaction partners lock Get3 into 
distinct and more defined conformations. 
The TA substrate induces Get3 to dynamically open 
 To determine the conformation of Get3 when bound to the TA substrate, we 
assembled Get3•TA complexes by in vitro translation of Bos1, a model GET 
substrate (Rao et al. 2016), in Escherichia coli lysate in the presence of Get3 and 
affinity-purified Get3•TA complexes via the 3xStrep-tag on Bos1 (Rao et al. 2016) 
(Figure 2.9A). Get3•TA complexes generated by this procedure were kinetically 
stable and highly efficient in TA targeting and insertion into the ER membrane (Rao 
et al. 2016) (Figures 2.10 and 2.11). In μs-ALEX measurements, AMPPNP•Get3•TA 
displayed a broader FRET distribution shifted toward lower E* values compared with 
AMPPNP•Get3 (Figure 2.9B). The distributions shifted further to lower FRET and 
peaked at E* values of ∼0.55–0.6 with ADP•Get3•TA and Get3•TA (Figure 2.9 C and 
D). In addition, BVA showed that, in contrast to AMPPNP•Get3, Get3•TA complexes 
exhibiting intermediate E* values displayed higher SD than the static limit in all 
nucleotide states (Figure 2.9 E–G). These observations indicate that Get3 also 
becomes more dynamic upon TA binding, and the observed E* values of 0.4–0.6 
result from averaging of Get3•TA complexes that interconvert between lower (<0.4) 
and higher (>0.6) FRET states on the sub-millisecond or faster timescale. Thus, 
contrary to the highly closed Get3•TA structure observed crystallographically 
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(Mateja et al. 2015), the TA substrate induces Get3 to dynamically sample open 
conformations. 
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Figure 2.9: The TA substrate induces Get3 to dynamically sample open 
conformations. (A) Scheme for generation and purification of Get3•TA complexes 
for μs-ALEX experiments. Green and red asterisks denote donor and acceptor dyes 
labeled on Get3. A 100-fold excess of unlabeled Get3 was included to ensure that, 
statistically, intradimer FRET of Get3 was measured even in cases of potential Get3 
tetramerization (Bozkurt et al. 2009, Rome et al. 2013, 2014). Experimental details 
are provided in Chapter 2.4. IVT, in vitro translation. (B–D) FRET histograms of 
Get3•TA complexes in AMPPNP-bound, ADP-bound, and nucleotide-free states, 
respectively. The outlines depict the FRET histograms of Get3 in the same nucleotide 
state without TA substrate and are shown for comparison; “n” denotes the number of 
observed doubly-labeled Get3 used to generate each FRET histogram. (E–G) BVAs 
of Get3•TA in AMPPNP-bound, ADP-bound, and nucleotide-free states, 
respectively. The red curves represent the SD expected for shot-noise-limited E*. 
Triangles denote the mean SD for individual FRET bins used to calculate the 
dynamic score (DS) and weighted dynamic score (WDS). 
30 
 
 
Figure 2.10: Prepared Get3•TA complexes are active in targeting and insertion 
into the ER. (A) Scheme of the TA targeting and insertion assay. Purified Get3•TA 
was presented to the ER from Δget3 yeast with or without nucleotide and/or Get4/5. 
Successful TA insertion results in glycosylation (glyc) of its C-terminal opsin tag, 
which can be visualized as a molecular weight shift after SDS-PAGE. (B) 
Representative SDS-PAGE autoradiograph (top) and its quantification (bottom) for 
the time courses of Get3•TA targeting and insertion shown for wild-type Get3 (black 
solid line) and mutant Get3(Δα8) (cyan) (see Figure 2.14). The dotted curve depicts 
the insertion efficiency for Get3•TA generated with Sgt2 and Get4/5 included during 
translation as described previously (Rao et al. 2016), and shows that the inclusion of 
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Sgt2 and Get4/5 is not necessary for generation of a functional Get3•TA complex. 
glyc, glycosylated; yRM, yeast rough microsome. 
 
Figure 2.11: Prepared Get3•TA complexes are kinetically stable. Purified 
Get3BDP•TACM (Rao et al. 2016) was presented to indicated concentrations of a TA 
trap, intein-cpSRP43 (Liang et al. 2016), and TA dissociation from Get3 was 
monitored through loss of FRET. The observed rate of TA dissociation is 
independent of trap concentration, indicating that intein-cpSRP43 acts as a passive 
trap to measure the intrinsic rate of Get3•TA spontaneous dissociation. The reported 
kdissociation value represents mean ± SD from the three measurements. 
 The Get3•TA complex was crystallized using a synthetic antibody (sAB), 
which binds at similar surfaces on Get3 as does Get4/5 (Mateja et al. 2015); it also 
specifically recognizes ATP-bound Get3, as does Get4/5 (Gristick et al. 2014, Mateja 
et al. 2015, Rome et al. 2014). Thus, a potential explanation for the difference 
between the crystallographic and single-molecule FRET data is that Get4/5 stabilizes 
a more closed conformation of Get3•TA, and this effect was mimicked by the sAB. 
We therefore tested the effect of Get4/5 on Get3 conformation using μs-ALEX. With 
apo-Get3, to which Get4/5 binds at a different surface than ATP•Get3 (Gristick et al. 
2015), Get4/5 did not significantly change the FRET histogram (Figure 2.12A and 
Figure 2.13). With ADP•Get3, which is distributed between low and high FRET states, 
Get4/5 shifted the distribution to predominantly high E* values (Figure 2.12B and 
Figure 2.13). With AMPPNP•Get3, which is already closed, Get4/5 induced a modest 
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but statistically significant shift of the FRET distribution to a distinct high-FRET 
state (Figure 2.12C and Figure 2.13). These results agree well with previous work 
showing that Get4/5 preferentially binds closed Get3 (Gristick et al. 2014, Rome et 
al. 2014). Importantly, binding of Get4/5 also shifted the distribution of ATP•Get3•TA 
to higher E* (Figure 2.12D, bars vs. orange outline). Compared with the FRET 
distribution of AMPPNP•Get3•Get4/5 before TA loading, the distribution after TA 
loading peaked at the same E* value but was substantially broader (Figure 2.12D, 
bars vs. teal outline). Thus, Get4/5 also biases Get3•TA to more closed 
conformations. Moreover, these data illustrate sequential changes in the 
conformation and dynamics of Get3 during the targeting pathway (Figure 2.12E): 
Starting with a static, closed AMPPNP•Get3•Get4/5 complex (black), TA loading 
induces conformational “breathing” of Get3 (light orange); upon dissociation from 
Get4/5, Get3 more frequently samples open conformations (teal) that become more 
dominant after ATP hydrolysis (dark orange). 
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Figure 2.12: Sequential opening of Get3 upon TA loading and Get4/5 release. 
(A–C) Effects of Get4/5 on the FRET histograms of apo-, ADP-, and AMPPNP-
bound Get3, respectively. (D) FRET histogram of Get3•TA bound with Get4/5 and 
ATP. The complex was generated by supplementing Get4/5 and excess ATP 
throughout the preparation to capture the conformation of the physiological initial 
loading complex (see Chapter 2.4). Since Get4/5 inhibits ATP hydrolysis (Rome et 
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al. 2013) and excess ATP is used, ATP turnover has no significant effect on the 
results. (E) Comparisons of FRET histograms of Get3 at different stages of the GET 
pathway. In A–D, the outlines depict the FRET histograms of indicated Get3 
complexes and are shown for comparison, and “n” denotes the number of observed 
doubly-labeled Get3 used to generate each FRET histogram. 
 
Figure 2.13: Adapted K-S tests for Get3•Get4/5 FRET histograms. Adapted K-S 
test to evaluate the significance of the differences between the FRET histograms of 
the indicated samples (see Chapter 2.4). The F (p < 0.05) values at each sample size 
m denote the fraction of 10 K-S tests from randomly selected subsets of data that 
yielded a statistically significant difference (p < 0.05), and were reported as mean ± 
SD, with n = 5. Histograms for which the F (p < 0.05) value rises slowly with m are 
considered similar (black line). Histograms for which the F (p < 0.05) value rises 
quickly with m are interpreted as significantly different (blue and red lines). 
TA is stably bound by the dynamically fluctuating Get3 
 The dynamic opening of the Get3•TA complex is unexpected, as 
crystallographic analyses suggested that in open Get3, the hydrophobic groove for 
TMD binding becomes discontiguous (Mateja et al. 2009, Suloway et al. 2009). 
Intriguingly, our recent (Rao et al. 2016) and current measurements showed that 
Get3•TA complexes exhibit high kinetic stability: using a membrane protein 
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chaperone, cpSRP43 (Jaru-Ampornpan et al. 2010, Liang et al. 2016), as an inert TA 
trap, the timescale for spontaneous dissociation of Bos1 from Get3 was measured to 
be ∼4 h (Figure 2.11). The lower limit for the lifetime of other Get3•TA complexes 
was 35–60 min (Rao et al. 2016). Thus, TAs are stably bound to Get3 despite the 
large-scale conformational fluctuations of Get3. 
 The simplest modification of the current model to explain these observations 
is that a 15-aa sequence termed helix α8, which was unresolved in most Get3 
structures and proposed to form a lid over the TA-binding groove (Mateja et al. 2009, 
2015), could prevent the escape of TA substrates during opening. Nevertheless, a 
structure of apo-Get3 [Protein Data Bank (PDB) ID code 3A36], in which α8 was 
resolved (Yamagata et al. 2010), suggests that the dimensions of α8 are unlikely to 
be sufficient to completely shield the helical domains and block TA escape in open 
Get3 (Figure 2.14A, α8 highlighted in cyan). To experimentally test the importance 
of α8, we replaced the conserved hydrophobic residues (199PMLNSFM) in this 
sequence with a GS linker (GGSGGGS) to generate mutant Get3(Δα8). Get3•TA 
complexes assembled with mutant Get3(Δα8) could be purified as a stable complex 
(Figure 2.14B) and are fully functional in TA targeting and insertion into the ER 
membrane (Figure 2.10B, cyan curve). These results show that shielding by α8 is 
insufficient to explain the high stability of the Get3•TA complex if the current model 
of Get3–TA interaction were the only possible interaction mode. Following the 
principle of thermodynamic coupling, the observation of TA-induced Get3 opening 
further predicts that the TA substrate can explore alternative modes for interacting 
with a more open Get3 that are energetically more favorable than the established 
interaction mode observed with closed Get3 (Figure 2.14C). The implications of 
these observations are elaborated on in the Discussion section. 
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Figure 2.14: α8 is not necessary for a stable Get3•TA complex. (A) Structure of 
apo-Get3 (PDB 3A36) highlighting helix α8 (cyan) that is resolved in one of the Get3 
subunits (yellow). The residues preceding and following α8 are highlighted in cyan 
in the other Get3 subunit (wheat). (B) Visualization of purified Get3•TA complexes, 
assembled with wild-type Get3 or mutant Get3(Δα8), by in-gel fluorescence (for 
Get3) and autoradiography (for TA). (C) Thermodynamic cycle showing the 
coupling of the TA-binding equilibrium (denoted by KTA and KTA’ for closed and 
open Get3, respectively) to the conformational equilibrium of Get3 opening (denoted 
by Kopen and Kopen’ for free and TA-loaded Get3, respectively). 
TA-induced Get3 opening drives membrane targeting 
At the junction of the Get3 helical and ATPase domains is a network of 
residues that interact across the dimer interface and contribute catalytic interactions 
with ATP (Bozkurt et al. 2009, Mateja et al. 2009, Suloway et al. 2009, Yamagata et 
al. 2010) (Figure 2.15A), raising the possibility that disruption of this network would 
interfere with the ability of Get3 to undergo regulated conformational changes. We 
tested two mutations in this network, D57N and E251A, which cause severe yeast 
growth defects under stress conditions (Mateja et al. 2009, Suloway et al. 2009). Both 
mutants bind ATP tightly but displayed ~100-fold slower ATPase activity than wild-
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type Get3 (Mateja et al. 2009) (Figure 2.15 B–E). Surprisingly, μs-ALEX 
measurements showed that these mutations bias Get3 toward closed conformations 
under different conditions. Get3(E251A) is more closed than Get3(WT) when bound 
with nucleotides (Figure 2.16 A–D), whereas Get3(D57N) is more closed than 
Get3(WT) in apo- and Get1CD-bound states (Figure 2.16 G–J). In the Get3•TA 
complex, the FRET distributions of mutant Get3(D57N) were shifted to higher E* 
with and without ATP and Get4/5 present (Figure 2.16 K and L), whereas only the 
FRET distribution of free Get3(E251A)•TA was shifted (Figure 2.16 E and F). 
Although the mutational effects on the FRET distributions of Get3•TA were modest, 
the changes are systematic compared with variations between replicates of data and 
are statistically significant (Figures 2.5 and 2.17). The different effects of the two 
mutations on the FRET distributions of Get3•TA also agreed well with biochemical 
analyses of these mutants described later (see Figures 2.20 and 2.21). Thus, point 
mutations at the Get3 catalytic site alter the conformation and regulation of its helical 
domains. 
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Figure 2.15: Interactions at the Get3 ATPase site. (A) Network of interacting 
residues at the catalytic site across the Get3 dimer interface. Get3-D57 is positioned 
near the γ-phosphate and coordinates the nucleophilic water. Get3-N61 forms a salt 
bridge with Get3-E251 from the opposing Get3 monomer (PDB 2WOJ). ADP•AlF4− 
is shown in space-fill. (B–D) ATP concentration dependences of observed ATP 
hydrolysis rate constants for wild-type Get3 and the mutants Get3(E251A) and 
Get3(D57N), respectively. (E) Summary of KM and kcat values for wild-type and 
mutant Get3’s derived from the data in B–D. All values are reported as mean ± SD 
(n ≥ 2). Get3(E251A) and Get3(D57N) retain high-affinity ATP binding but are 
defective in ATP hydrolysis. 
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Figure 2.16: Point mutations at the ATPase active site bias Get3 to more closed 
conformations. (A–D) FRET histograms of Get3(E251A) in apo-, AMPPNP-, 
ADP-, and Get1CD-bound states, respectively. (E and F) FRET histograms of 
Get3(E251A)•TA without (E) or with (F) Get4/5 and ATP bound. (G–J) FRET 
histograms of Get3(D57N) in apo- and AMPPNP-, ADP-, and Get1CD-bound states, 
respectively. (K and L) FRET histograms of Get3(D57N)•TA without (K) and with 
(L) Get4/5 and ATP bound. In all histograms, the orange outlines depict the FRET 
histograms of wild-type Get3 under the same conditions, and “n” denotes the number 
of observed doubly-labeled molecules used to generate each FRET histogram. 
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Figure 2.17: Comparisons of FRET histograms between wild-type and mutant 
Get3 complexes. (A–D) Differences between FRET histograms of indicated wild-
type and mutant Get3 complexes. (E and F) Differences between replicates of µs-
ALEX measurements for Get3•TA and Get3(E251A)•TA samples. The differences 
in the FRET histograms shown in A, C, and D between wild-type and mutant Get3 
are systematic. In comparison, the differences in the FRET histograms between 
replicates of data shown in E and F are randomly distributed across E*, and the 
difference in the FRET histograms shown in B is smaller and more random. (G) 
Adapted K-S tests to evaluate the significance of the differences between the FRET 
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histograms of the indicated samples (see Figure 2.13, Chapter 2.4). Adapted K-S tests 
for molecules from the same sample usually result in p > 0.05 regardless of m (pink 
and dark blue lines), and serve as negative controls for the absence of a significant 
difference. Histograms for which the F (p < 0.05) value rises slowly with m are 
considered similar (light blue line). Histograms for which the F (p < 0.05) value rises 
quickly with m are interpreted as significantly different (black, orange, and green 
lines). 
To assess if the conformational bias in Get3(D57N) and Get3(E251A) 
disrupts Get3 function, we tested the activities of these mutants in mediating TA 
targeting and insertion into the ER membrane. Without Get4/5 present, 
Get3(D57N)•TA and Get3(E251A)•TA were up to threefold and fivefold slower, 
respectively, than wild-type Get3•TA in targeting and insertion (Figure 2.18 A, C, 
and E). However, physiological amounts of Get4/5 (Ghaemmaghami et al. 2003) 
nearly abolished TA insertion with both mutants, without substantially affecting TA 
insertion by wild-type Get3 (Figure 2.18 B, D, and F). These mutational defects were 
observed regardless of the nucleotide state of Get3•TA complexes (Figure 2.18 A–
F); the slower phase of the insertion reactions with apo-Get3 was due to the 
nucleotide requirement for recycling Get3 from the ER membrane during multiple 
rounds of TA targeting (Mariappan et al. 2011, Rome et al. 2014, Wang et al. 2011). 
Together, these results show that TA-induced Get3 opening is essential for 
membrane targeting of the Get3•TA complex under conditions that mimic the 
physiological situation, where the Get1/2 receptor and Get4/5 complex must compete 
for binding to Get3. 
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Figure 2.18: Get3 active site mutants block the targeting of Get3•TA complexes. 
Time courses for targeting and insertion of wild-type and mutant Get3•TA complexes 
in the absence (A, C, and E) and presence (B, D, and F) of 0.5 μM Get4/5. The 
nucleotides used in the insertion reactions are as follows: 2 mM ATP in A and B, 2 
mM ADP in C and D, and no nucleotides in E and F. All experiments were repeated 
on different days (n ≥ 2) and are plotted as mean ± SD. yRM, yeast rough microsome. 
The following data indicate that the effects of these Get3 mutants did not arise 
solely from the failure to hydrolyze ATP, but rather from defects in undergoing TA-
induced conformational changes. Even with AMPPNP bound, targeting and insertion 
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from wild-type Get3•TA was efficient (compare black lines in Figure 2.19 vs. Figure 
2.18A); thus, ATP hydrolysis per se is not required for membrane targeting (Bozkurt 
et al. 2009). Wild-type AMPPNP•Get3•TA also tolerated the presence of Get4/5 and 
allowed TA insertion (Figure 2.19, purple), albeit three- to five-fold more slowly than 
the reaction of ATP•Get3•TA with Get4/5 present (Figure 2.18B, black). Thus, ATP 
hydrolysis contributes three- to five-fold, but is not obligatory for the exchange of 
Get4/5 with Get1/2 on the Get3•TA complex. Further, the ATP occupancy of 
Get3(D57N)•TA and Get3(E251A)•TA complexes was measured to be 39% and 
5.8%, respectively (Table 2.1); even if only the ADP- or nucleotide-free targeting 
complexes were active, these ATP occupancies predict that the two mutants would 
retain 61% and 94%, respectively, of the targeting activity of wild-type Get3, which 
were insufficient to explain their targeting defects. Finally, the Get4/5-specific 
targeting defect of both Get3 mutants was observed regardless of the added 
nucleotide (Figure 2.18 A–F). Assuming the simplest model in which the observed 
insertion occurs from the fraction of Get3•TA complexes that acquired a targeting-
competent conformation, the biochemical data suggested that the defect of mutant 
Get3(E251A)•TA in attaining the active conformation was ∼70-fold after ATP 
hydrolysis [Figure 2.18D, comparing the time required for 11% insertion with 
ADP•Get3•TA vs. ADP•Get3(E251A)•TA]. These results underscore the essential role 
of TA-induced Get3 conformational change in driving membrane targeting. 
 
Figure 2.19: Get3•TA targeting and insertion in the presence of AMPPNP. Time 
courses for targeting and insertion of wild-type AMPPNP•Get3•TA with and without 
Get4/5 or mutant Get4(D74K)/5 (see Figure 2.21) present. All experiments were 
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repeated on different days (n ≥ 2) and are plotted as mean ± SD. yRM, yeast rough 
microsome. 
 
Table 2.1: Determination of ATP content in Get3 and Get3•TA. A luminescence-
based ATP detection kit was used to determine the ATP concentrations for different 
Get3 and Get3•TA samples at 1 μM. Get3(D57N) shows higher nucleotide retention 
compared with Get3(E251A) and Get3(WT). All values are reported as mean ± SD, 
with n = 3. 
The Get3 active site couples the TA-binding site to the Get3-effector interaction 
surface 
 The Get4/5-specific targeting defects of Get3(D57N) and Get3(E251A) 
suggest that these mutants fail to dissociate from Get4/5 after TA loading, and thus 
block the subsequent interaction of Get3 with the Get1/2 receptor complex at the ER 
membrane. To test this hypothesis, we measured the Get3–Get4/5 interaction using 
an established assay based on the fluorescence enhancement of acrylodan labeled at 
Get4(S48C/C177T) upon Get3 binding (Rome et al. 2014). Equilibrium titrations 
showed that while wild-type Get3•TA bound Get4/5 much more weakly than 
ATP•Get3, as observed previously (Rome et al. 2014), mutant Get3(D57N)•TA and 
Get3(E251A)•TA retained high-affinity binding to Get4/5 (Figure 2.20 and Table 
2.2). Thus, small defects in Get3 opening (Figure 2.16 E, F, K, and L) could severely 
block the TA-induced disassembly of the Get3•Get4/5 complex. 
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Figure 2.20: The TA substrate regulates the Get3–Get4 interaction. (A and B) 
Representative equilibrium titrations to measure the binding of Get4/5 to wild-type 
and mutant Get3 in the ATP-bound (A) and TA-bound (B) states. arb., arbitrary. 
 
 How do TAs induce the dissociation of Get3 from Get4/5? Structural work 
showed that Get4 contacts ATP-bound Get3 at two interfaces: an anchoring interface, 
which enables stable binding, and a regulatory interface, which regulates Get3’s 
ATPase activity (Gristick et al. 2014) (Figure 2.21A). We introduced the 
Get4(D74K) mutation that disrupts the salt bridge between Get4-D74 and Get3-K69 
at the regulatory interface (Gristick et al. 2014) (Figure 2.21B). The affinity of Get3 
for wild-type Get4/5 relative to mutant Get4(D74K)/5 provides a measure for the 
energetic contribution of this salt bridge to Get3-Get4/5 binding. While the 
Get4(D74K) mutation weakened the binding to ATP•Get3 fivefold (Gristick et al. 
2014), the mutational effect was >20-fold with AMPPNP•Get3•TA and then became 
negligible with Get3•TA (Figure 2.21C, black bars and Table 2.2). These results 
illustrate sequential changes at the Get3–Get4 regulatory interface, where the 
Get3(K69)-Get4(D74) salt bridge is ancillary before TA binding, becomes stronger 
upon TA loading, and then dissolves after nucleotide hydrolysis and release from 
Get3•TA. 
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Figure 2.21: The TA substrate induces a rearrangement of the Get3–Get4 
interaction interface. (A) Get3 interacts with Get4 via two interfaces: an anchoring 
interface (magenta spheres, which highlight residues whose mutations reduce the 
affinity between ATP-bound Get3 and Get4/5) and a regulatory interface (blue 
spheres, which highlight conserved residues that may contact Get4/5) (Gristick et al. 
2014). (B) Get3-K69 forms a putative salt bridge (dotted line) with Get4-D74 at the 
regulatory interface (PDB 4PWX). Mutation of Get3-K69 or Get4-D74 did not 
substantially reduce Get3-Get4/5 binding but disrupted the ability of Get4/5 to 
regulate ATP hydrolysis by Get3 (Gristick et al. 2014). (C) Summary of the effects 
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of the Get4(D74K) mutation on the binding affinity of Get4/5 for wild-type and 
mutant Get3 (Kbinding = 1/Kd) in the indicated complexes. Data are from Table 2.2 are 
reported as mean ± propagated error, with n ≥ 2. (D) Representative equilibrium 
titrations to measure the binding of Get4(D74K)/5 to wild-type and mutant Get3•TA 
complexes. Dashed lines are the binding curves of wild-type Get4/5 to the 
corresponding Get3 variant (from Figure 2.20B) and are shown for comparison. (E) 
Time courses for targeting and insertion of Get3(D57N)•TA in the presence of ATP 
and indicated Get4/5 variants (n = 2). 
 
Table 2.2: Summary of equilibrium binding affinities between Get4/5 and Get3 
variants in different substrate and nucleotide states. All values are reported as 
mean ± SD (n ≥ 2). 
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 Importantly, while the TA substrate failed to weaken the binding of 
Get3(D57N) and Get3(E251A) with wild-type Get4/5 (Figure 2.20B), it did with 
mutant Get4(D74K)/5 (Figure 2.21D), suggesting that the Get3 active site mutants 
exert their effects by blocking changes at the Get3–Get4 regulatory interface. 
Analysis of the mutational effects of Get4(D74K) on the Get3 active site mutants 
further showed that Get3(E251A) is primarily defective in removing the Get3-Get4 
contact at the regulatory interface after nucleotide hydrolysis and release, while 
Get3(D57N) is defective in rearranging this interface both before and after ATP 
hydrolysis (Figure 2.21C, red and blue bars and Table 2.2). These data agreed well 
with the different effects of these mutations on the FRET distributions of Get3•TA 
and ATP•Get3•TA (Figure 2.16 E and F vs. K and L), and together they showed that 
the catalytic residues at the Get3 active site provide key functional links between the 
TA-binding site and the Get4/5 interaction surface of Get3. Finally, the Get4(D74K) 
mutation abolished the inhibitory effect of Get4/5 on the targeting of 
Get3(D57N)•TA (Figure 2.21E) and wild-type AMPPNP•Get3•TA (Figure 2.19), 
indicating that the TA-induced rearrangements at the Get3–Get4 regulatory interface 
directly impact targeting efficiency. 
2.3 DISCUSSION 
Across all organisms, targeting complexes guide nascent proteins to diverse 
cellular destinations. These complexes must bind substrate proteins with high overall 
stability, while also readily switching structure and function to drive these vectorial 
processes. In this work, single-molecule fluorescence spectroscopy coupled with 
biochemical analyses provides a unifying model to explain how these complex 
demands are met during TA targeting by the Get3 ATPase. In contrast to previous 
models, TA loading destablizes a static, closed Get3•TA complex and induces Get3 
to rapidly sample open conformations, and TA substrates are stably trapped in the 
rapidly fluctuating Get3. Point mutations at the ATPase active site bias Get3 toward 
closed conformations, uncouple TA binding from substrate-induced Get3•Get4/5 
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disassembly, and inhibit the targeting of the Get3•TA complex to the ER membrane. 
These data demonstrate how the substrate-induced dynamic opening of Get3 
provides a dual mechanism that allows the targeting complex to both retain substrates 
with high affinity and drive the exchange of Get3’s interaction partners required for 
the ER targeting of TAs. 
The substrate-induced opening of Get3 is unexpected, given the large and 
contiguous hydrophobic groove in closed Get3 that appears highly conducive to TA 
binding (Bozkurt et al. 2009, Mateja et al. 2009, 2015) as well as the high kinetic 
stability of Get3•TA complexes (Rao et al. 2016) (Figure 2.11). The TA-induced 
opening of Get3 further suggests that the TA substrate explores alternative sites and 
conformations for interacting with Get3 besides the previously observed docking of 
the TA-TMD at the well-defined hydrophobic groove in closed Get3, and that, 
collectively, these alternative Get3–TA interaction modes are energetically more 
favorable than the established mode. In analogy to membrane protein substrates 
bound to the Skp and SurA chaperones (Burmann et al. 2013, Thoma et al. 2015), it 
is plausible that TA substrates sample multiple transient interaction sites during Get3 
opening, and TAs could be retained because interaction with alternative sites in Get3 
is more favorable than with solvent. This model would explain, in part, the weak 
electron density for TA-TMDs in previous Get3•TA structures (Mateja et al. 2015). 
Alternatively, or in addition, the rapid conformational fluctuations of Get3 could 
enable its reclosing to kinetically outcompete potential TA dissociation from the 
targeting complex during Get3 opening. Potential tetramerization of Get3 upon TA 
binding (Bozkurt et al. 2009, Rome et al. 2013) could provide another mechanism to 
retain substrate in a more open Get3; as a recent study did not detect stable tetrameric 
Get3•TA complexes and showed that dimeric Get3•TA is active in mediating TA 
insertion (Mateja et al. 2015), the precise roles of Get3 tetramerization remain to be 
determined. Finally, increased conformational entropy in these more dynamic 
models could contribute to the overall stability of the targeting complex. Regardless 
of the specific mechanism of substrate retention, our results collectively show that 
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substrate proteins can be stably bound to a targeting factor/chaperone while the latter 
undergoes large-scale fluctuations between open and closed states. 
The targeting pathway demands extensive changes in the activities of Get3 
before and after substrate loading. Before TA binding, Get3 must be ATP-bound and 
tightly bound to Get4/5, whereas after TA loading, Get3 must hydrolyze ATP and 
detach from Get4/5 so that it can instead interact with the Get1/2 receptors at the ER 
membrane. The results from this and previous work (Gristick et al. 2014, Rome et al. 
2013, 2014) demonstrate that nucleotide, together with the Get4/5 complex, is 
responsible for inducing a highly closed conformation of Get3. Although these 
results provide an attractive mechanism to explain how Get3 efficiently captures TA 
substrates at early stages of the pathway, they fail to explain the functional switches 
of Get3 required for the targeting phase of the pathway. The substrate-induced 
opening of Get3 provides an attractive mechanism to drive this functional switch, 
and thus resolves this dilemma. 
Experimentally, the important role of substrate-induced Get3 opening is 
demonstrated by the D57N and E251A mutations at the Get3 ATPase site, both of 
which bias Get3 toward closed conformations. These mutants uncouple TA binding 
from TA-induced changes in Get3’s biochemical activities, including dissociation 
from Get4/5 and efficient targeting of TA substrates to the ER membrane. Although 
the targeting defect of Get3(D57N) was previously attributed to failed ATP 
hydrolysis (Mariappan et al. 2011, Mateja et al. 2009, Wang et al. 2011), complete 
analysis of the targeting reaction in all nucleotide states, including the non-
hydrolyzable ATP analog AMPPNP, showed that the targeting defects of Get3 active 
site mutants are largely conformational in origin (Figure 2.22, step 5). The majority 
of the defects of Get3(D57N) and Get3(E251A) can be attributed to their failures to 
undergo TA-induced dissociation from Get4/5, which competes with the Get1/2 
receptors for binding Get3. In addition, the three- to six-fold defects of these mutants 
in ER targeting in the absence of Get4/5 suggest that TA-induced Get3 opening 
facilitates the binding and remodeling of the targeting complex by Get1/2. By 
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combining these mutants with disruptions at the Get3–Get4 regulatory interface, we 
further demonstrate sequential TA-induced adjustments at the Get3–Get4 interaction 
surface that drive their disassembly, and how Get3 active site mutations disrupt this 
relay of signal. Together, these data reveal a tightly coupled channel of 
communication between the TA-binding site, ATPase catalytic site, and effector 
interaction surfaces on Get3. 
Collectively, our results illustrate how substrate-induced dynamic opening 
switches Get3 from a TA-loading mode to a targeting mode, thus initiating 
downstream steps in the GET pathway (Figure 2.22). At early stages, ATP and 
Get4/5 lock Get3 into an occluded conformation, in which Get3 is closed and 
ATPase-inhibited (Gristick et al. 2014, Rome et al. 2013), and thus primed for TA 
capture (step 1). The closed Get3•TA-TMD structure, obtained with mutant 
Get3(D57N) and a sAB mimicking the interaction sites and biochemical activities of 
Get4/5 (Mateja et al. 2015), likely represents the initial ATP•Get3•TA•Get4/5 
complex. TA loading destabilizes this static structure and induces Get3 to undergo 
rapid conformational fluctuations to explore the more open state (step 2). These 
changes in the TA-binding domain are transmitted via the Get3 catalytic site to 
induce rearrangements at the Get3–Get4 interface, shifting stabilizing interactions 
from the anchoring interface to the regulatory interface (step 2). At this stage, 
spontaneous Get4/5 dissociation from Get3 (step 3), which is rapid despite the high 
stability of the complex (Rome et al. 2014), allows Get3•TA to further open and 
enables TA-induced ATPase activation (step 4). Opening of Get3 becomes more 
extensive after ATP hydrolysis (step 5), rendering the dissociation of Get4/5 
irreversible and priming Get3 for interaction with the Get1/2 receptors instead (step 
6). In addition, dynamic opening of the Get3•TA complex could provide a facile 
pathway for its remodeling by the Get1/2 receptor complex, facilitating TA release 
and insertion into the ER membrane (step 6); this may explain the modest but still 
significant defects of the Get3 active site mutants in TA insertion in the absence of 
Get4/5. Importantly, while Get1 was primarily responsible for opening Get3 in most 
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previous models (Kubota et al. 2012, Mariappan et al. 2011, Stefer et al. 2011, Wang 
et al. 2011), our findings show that the TA substrate itself initiates this opening to 
vectorially drive late stages of the targeting cycle. 
 
Figure 2.22: Model for how TA-induced Get3 opening drives the membrane 
targeting of the Get3•TA complex. Step 1: ATP•Get3 is bound to Get4/5, which 
induces Get3 to a closed, occluded conformation that inhibits ATP hydrolysis. TA is 
transferred from Sgt2 to Get3 in the Sgt2•Get4/5•Get3•TA complex, in which Get4/5 
bridges Sgt2 and Get3. Step 2: TA loading induces Get3 to sample more open 
conformations, with concomitant adjustment at the Get3•Get4/5 interface that causes 
the regulatory interface to become the predominant stabilizing interaction. Step 3: 
Get4/5 spontaneously and reversibly dissociates from the conformationally adjusted 
Get3•TA complex. Step 4: TA induces Get3 to rapidly hydrolyze ATP after Get4/5 
dissociation. Step 5: After ATP hydrolysis, Get3•TA becomes more open, attaining 
a strained conformation that prevents rebinding of Get4/5. Step 6: The strained 
Get3•TA complex is primed for targeting to and remodeling by the Get1/2 receptors 
at the ER membrane. Step 7: Get1/2 facilitates TA disassembly from Get3 and TA 
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insertion into the membrane. Binding of ATP and Get4/5 releases Get3 from the 
membrane receptors, recycling it for additional rounds of targeting. The inhibition 
marks denote steps inhibited by the E251A and D57N mutations, with inhibition of 
step 5 being responsible for the majority of defects of these mutants on the overall 
targeting reaction under physiological conditions. 
Current models of substrate interactions with targeting factors and molecular 
chaperones often fall into the category of lock-and-key mechanisms, in which 
substrate proteins fit into pre-organized, well-structured grooves or pockets in the 
substrate-binding domain (Ferbitz et al. 2004, Janda et al. 2010, Keenan et al. 1998, 
Merz et al. 2008, Xu et al. 1997). Although these mechanisms provide excellent 
explanations for how substrate proteins are captured, they also generate 
thermodynamic sinks that inhibit subsequent steps in the pathway, analogous to the 
situation described for Get3 (Shan 2016). Our observations provide a precedent for a 
distinct class of models, in which rapid conformational fluctuations of a targeting 
factor/chaperone generate a “protean trap” that can retain substrates with high 
stability, and the dynamic nature of the complex enables functional switches to guide 
progression of the pathway. Analogous protean traps may provide an effective 
mechanism in other targeting factors, chaperones, and transporters that need to retain 
substrates with high affinity, while driving vectorial pathways that require distinct 
functions to be switched “on” and “off” in a sequential and coordinated manner. 
2.4 MATERIALS AND METHODS 
Plasmids 
Plasmids for recombinant expression of Get3, Get4/5, Get1CD, and a 
superactive mutant of the cpSRP43 chaperone (intein-cpSRP43) and for in vitro 
translation of 3xStrep-SUMOnc-Bos1-opsin have been described (Liang et al. 2016, 
Rao et al. 2016, Rome et al. 2013, 2014). DNA encoding 2xStrep-Sbh1 was in the 
pACYCDuet-1 vector. Plasmids encoding mutant proteins were generated using 
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QuikChange site-directed mutagenesis (Stratagene) or FastCloning (Li et al. 2011), 
and were confirmed with DNA sequencing (Laragen). 
Biochemical reagents 
 Get3, Get4/5, Get1CD, and intein-cpSRP43 were expressed and purified as 
described (Liang et al. 2016, Rao et al. 2016, Rome et al. 2013, 2014). E. coli S30 
lysate and T7 RNA polymerase were prepared as described (Rao et al. 2016, Saraogi 
et al. 2011). Microsomes were prepared from Δget3 yeast cells as described (Rome 
et al. 2013, Rothblatt & Meyer 1986, Schuldiner et al. 2008). 
 Get3•TA complexes for μs-ALEX and insertion assays were generated as 
described (Rao et al. 2016) with modifications. For μs-ALEX, the model TA 3xStrep-
Bos1-opsin (Rao et al. 2016) was in vitro-translated in E. coli S30 lysate for 2 hr at 
30°C in the presence of 2 μM Get3 (1:100 double-labeled to unlabeled), with or 
without 2 μM Sgt2 and 2 μM Get4/5 present. Complexes containing 3xStrep-tagged 
TA were purified using Strep-Tactin Sepharose (IBA Life Sciences) as described 
(Rao et al. 2016). Omission of Sgt2 and Get4/5 in this procedure does not change the 
targeting and insertion activity of Get3•TA (Figure 2.10B). To characterize the 
effects of Get4/5 and ATP on Get3•TA conformation (Figures 2.12D and 2.16 F and 
L), 0.5 μM Get4/5 and 2 mM ATP were present throughout the purification, and 
excess Get4/5 and ATP were supplemented to the purified complex. Get3BDP•TACM 
complexes used in Fig. S4B were generated as described (Rao et al. 2016). 
 Recombinant Get3•Sbh1 complexes were purified as described (Mateja et al. 
2015) with modifications. Untagged Get3 and 2xStrep-Sbh1 were coexpressed in 
One Shot BL21 Star (DE3) (Invitrogen) for 6 hr at 26°C after induction with 0.1 mM 
isopropyl β-D-1-thiogalactopyranoside at OD600 ∼ 0.8. Cells were disrupted by 
sonication in lysis buffer [50 mM Tris·HCl (pH 7.6), 300 mM NaCl, 5 mM β-
mercaptoethanol, protease inhibitors]. Complexes containing 2xStrep-Sbh1 were 
purified using Strep-Tactin Sepharose followed by Superdex 200 10/300 GL (GE 
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Healthcare) in GET buffer [50 mM KHEPES (pH 7.4), 150 mM KOAc, 5 mM 
Mg(OAc)2, 1 mM DTT, 10% glycerol] (Figure 2.23). 
 
Figure 2.23: Purification of wild-type and mutant Get3•TA complexes. (A–C) 
Gel filtration chromatograms for recombinantly expressed and purified 
Get3•2xStrep-Sbh1 complexes made with Get3(WT), Get3(E251A), and 
Get3(D57N), respectively. Green and purple lines denote A280 and A260 readings, 
respectively, normalized to the peak A280 value. Fractions corresponding to the 
dominant peak were collected for each complex. The difference in elution volumes 
of recombinant wild-type and mutant Get3•TA has been noted previously (Mateja et 
al. 2015). Get3(D57N)•TA displays a higher ratio of A280 to A260 compared with 
Get3(WT)•TA and Get3(E251A)•TA, consistent with the higher ATP retention in 
this mutant complex determined in Table 2.1. 
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Fluorescence labeling 
 We have described a strategy to site-specifically label Get3 at a ybbR tag 
inserted between residues 110 and 111 via Sfp-catalyzed incorporation of dye-CoA 
conjugates; ybbR insertion and fluorescence labeling do not perturb Get3 function 
(Rao et al. 2016). Using this strategy, we stochastically double-labeled Get3 dimers 
with a 1:1 ratio of CoA-conjugated Cy3B-maleimide (GE Healthcare) or ATTO 550-
maleimide (ATTO-TEC) and CoA-conjugated ATTO 647N-maleimide (ATTO-
TEC) at the α4-α5 loop. Donor- or acceptor-only Get3’s were generated by labeling 
with one of the dyes. CoA-conjugated BODIPY FL-maleimide (Thermo Fisher 
Scientific) was used to generate the Get3BDP used in Figure 2.11. 
Get4(C177T/S48C)/5 and Get4(C177T/S48C/D74K)/5 were labeled with acrylodan 
as described (Rome et al. 2014). 
Biochemical assays 
50 µL TA targeting and insertion reactions were initiated by adding 10 μL of 
Δget3 microsomes to purified Get3•TA complexes in which [35S]-methionine–
labeled TA was normalized to 40,000 dpm. 2 mM nucleotide and/or 0.5 μM Get4/5 
was included where indicated. Reactions were incubated at 26°C; at indicated time 
points, 6 μL samples were removed and quenched by addition of 2×SDS buffer and 
flash-freezing in liquid nitrogen. Samples were analyzed by SDS-PAGE and 
autoradiography. 
Equilibrium-binding measurements between Get3 and acrylodan-labeled 
Get4/5 were performed as described (Rome et al. 2014). Get3BDP•TACM dissociation 
experiments were performed as described (Rao et al. 2016), except that indicated 
concentrations of intein-cpSRP43 were used as a chase instead of unlabeled Get3 
(which we found to modestly accelerate TA dissociation). Multi-site, multi-turnover 
ATPase rate constants for Get3 were measured as described (Rome et al. 2013). The 
ATP concentrations in Get3 and Get3•TA samples were quantified using a 
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luminescent ATP detection assay kit (ab113849; Abcam) per the manufacturer’s 
instructions. 
µs-ALEX measurements 
 All proteins were ultracentrifuged in a TLA 100 rotor (Beckman Coulter) at 
100,000 rpm for 1 hr at 4°C to remove aggregates before all measurements. Get3 
samples were diluted to ∼100 pM in GET buffer containing 0.3 mg/mL BSA and 
indicated interaction partners. Based on previously determined Kd values (Rome et 
al. 2013, 2014), saturating amounts of each interaction partner (2 mM AMPPNP, 4 
mM ADP, 10 μM Get1CD, 4 μM Get4/5) were used to ensure that all observed Get3 
molecules were ligand-bound. Samples were placed in a closed chamber made by 
sandwiching a perforated silicone sheet (Grace Bio-Labs) with two coverslips to 
prevent evaporation. Data were collected over 30–60 min using an ALEX–
fluorescence-aided molecule sorting setup (Kapanidis et al. 2004) with two single-
photon Avalanche photodiodes (PerkinElmer) and 532-nm and 638-nm continuous 
wave lasers (Coherent) operating at 135 μW and 80 μW, respectively. 
µs-ALEX data analysis 
All single molecule FRET (smFRET) data analyses, including burst search, 
burst selection, and BVA, were performed using FRETBursts, a Python-based open-
source burst analysis toolkit for confocal smFRET (Ingargiola et al. 2016). A dual-
channel burst search (Nir et al. 2006) was performed to isolate the photon streams 
from species containing FRET pairs versus background noise and species containing 
donor or acceptor only. Each burst was identified as a minimum of 10 consecutive 
detected photons with a photon count rate at least 15-fold higher than the background 
photon count rate during both donor and acceptor excitation periods. Since the 
background rate can fluctuate within a measurement, the background rate was 
computed for every 50 second interval according to maximum likelihood fitting of 
the interphoton delay distribution. The identified bursts were further selected 
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according to the following criteria: (i) nDD + nDA ≥ 25 and (ii) nAA ≥25, where nDD is 
the number of photons detected from donor during donor excitation, nDA is the 
number of photons detected from acceptor during donor excitation, and nAA is the 
number of photons detected from acceptor during acceptor excitation. 
The relative E* and stoichiometry (S) for each burst were calculated using the 
following equations: 
𝐸∗  =  
𝑛𝐷𝐴
𝑛𝐷𝐷  +  𝑛𝐷𝐴
,            [2.1] 
𝑆 =  
𝑛𝐷𝐷  +  𝑛𝐷𝐴
𝑛𝐷𝐷  +  𝑛𝐷𝐴  +  𝑛𝐴𝐴
,            [2.2] 
E* corresponds to actual FRET efficiency if three conditions are met: (i) no donor 
fluorescence leaks into the acceptor detection channel (lk = 0), (ii) no acceptor is 
directly excited by the donor excitation laser (dir = 0), and (iii) the quantum yields 
and detection efficiencies for donor and acceptor are the same (γ = 1) (Lee et al. 
2005). Although these conditions are not met in most cases, the contributions of lk, 
dir, and γ to the actual FRET efficiency are constant as long as the same optical setup 
and FRET pair are used throughout all measurements. Importantly, we did not 
observe significant changes in the quantum yields of donor and acceptor dyes 
depending on local environments (Figure 2.7). Therefore, conformational changes in 
Get3 that change the actual FRET efficiency will also change the E* value, and the 
trend of the changes with different binding partners will be the same. FRET 
histograms were obtained by 1D projection of 2D E*-S plots onto the E* axis after 
dual-channel burst search. 
 To determine the statistical significance of the differences between FRET 
histograms, we adapted the nonparametric two-sample Kolmogorov–Smirnov (K-S) 
test (Feller 1948, Young 1977). As noted earlier, the K-S test tends to be overly 
sensitive to data with a large sample size, and we found the same to be true if this test 
was applied without modification to single-molecule data; moreover, it is important 
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to distinguish between statistical versus biological significance of the difference 
between histograms for different sets of data, which contain intrinsic variability from 
instrument, sample preparation, and other factors (Cox et al. 1988, Lampariello 
2000). To obtain more reliable comparisons, we regenerated FRET histograms from 
randomly selected subsets (with sample size m) of the complete data for each 
experimental condition and performed the K-S test. Ten repetitions of this process 
generated a statistical significance score, defined as the fraction of comparisons that 
gave p < 0.05, for each value of m. This process was repeated five more times for 
each value of m and for data subsets with different m values, and the dependence of 
the statistical significance on sample size was plotted. Molecules with E* < 0.3 were 
excluded from the histograms in this analysis, as the low FRET bursts could arise 
from photophysical artifacts and were not interpreted in this study. As shown in 
Figures 2.13 and 2.17G, the statistical significance of the difference remains low even 
at high m (> 4,000) for histograms that are the same or similar, whereas the statistical 
significance of the difference increases rapidly with increasing m for histograms that 
are different. 
 BVA was performed to investigate sub-millisecond dynamics of Get3 as 
described (Torella et al. 2011). Equation 2.3 was used to compute the static limit, 
defined as the expected SD of a FRET distribution due to photon statistics (shot 
noise) for a given E*: 
𝜎𝐸
∗  =  √
𝐸∗(1 − 𝐸∗)
𝑛
,            [2.3] 
where n = nDD + nDA. The observed mean FRET SD (SD of E*) for each molecule 
was computed using Equation 2.4: 
𝑆𝐷 𝑜𝑓 𝐸∗  =  √
1
𝑀
∑(𝑒𝑖
∗ − 𝐸∗)2
𝑀
𝑖=1
,            [2.4] 
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in which e* and E* are relative FRET efficiencies (calculated from Equation 2.1) of 
a subburst (a subset of each burst that contains a constant number of consecutive 
photons) and a burst, respectively, and M is the number of subbursts in the burst. A 
subburst size (nsub = nsub,DD + nsub,DA) of five was used in this study. 
 To quantitatively represent the dynamics of molecules from the BVA, we 
calculated a dynamic score (DS) for each sample as follows. To reduce error that 
could arise from individual bursts, which contain a small number of subbursts, we 
first binned bursts along the E* axis into 20 bins with a bin width of 0.05. All of the 
subbursts within bursts in each bin were then used to calculate the mean FRET SD 
for each bin (SDE*) using Equation 2.5 (Torella et al. 2011): 
𝑆𝐷𝐸∗  =  √ ∑ ∑ [
𝑒𝑖𝑗
∗ −  µ
∑ 𝑀𝑖
]
𝑀𝑖
𝑗=1𝑖 𝑤ℎ𝑒𝑟𝑒
𝐿 ≤ 𝐸𝑖
∗ < 𝑈
,            [2.5] 
where µ =  ∑ ∑ [
𝑒𝑖𝑗
∗
∑ 𝑀𝑖
]
𝑀𝑖
𝑗=1𝑖 𝑤ℎ𝑒𝑟𝑒
𝐿 ≤ 𝐸𝑖
∗ < 𝑈
, L is the lower bound (E* − 0.025) of the bin, U 
is the upper bound (E* + 0.025) of the bin, Mi is the number of subbursts in the ith 
burst, and eij* is the relative FRET efficiency of the jth subburst in the ith burst. The 
DS was calculated using Equation 2.6 (Torella et al. 2011): 
𝐷𝑆 =  √ ∑ (𝑆𝐷𝐸∗ − 𝑆𝐷𝐸∗,𝑠𝑡𝑎𝑡𝑖𝑐)
2
𝑆𝐷𝐸∗−𝑆𝐷𝐸∗,𝑠𝑡𝑎𝑡𝑖𝑐  > 0
,            [2.6] 
where SDE*,static is the SDE* of simulated static molecules using the Monte Carlo 
method. To ensure that the score reports on the dynamics of the majority of the 
molecules in a given sample, only bins with ≥ 8% of the total number of bursts in the 
entire FRET histogram were used to calculate DS, and the SDE* values for each of 
these bins are denoted with triangles in BVA plots. To take into account the different 
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numbers of bursts in each bin, we also computed a weighted dynamic score (WDS) 
to weight bins according to their size using Equation 2.7: 
𝑊𝐷𝑆 =  √ ∑ (
𝑁𝐸∗
∑ 𝑁𝐸∗
) × (𝑆𝐷𝐸∗ − 𝑆𝐷𝐸∗,𝑠𝑡𝑎𝑡𝑖𝑐)
2
𝑆𝐷𝐸∗−𝑆𝐷𝐸∗,𝑠𝑡𝑎𝑡𝑖𝑐  > 0
,            [2.7] 
where NE* is the number of bursts in each bin. 
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C h a p t e r  3  
 
 
A CHAPERONE LID ENSURES EFFICIENT AND PRIVILEGED 
CLIENT TRANSFER DURING TAIL-ANCHORED PROTEIN 
TARGETING 
 
Adapted from: 
Chio, U.S., Chung, S., Weiss, S., and Shan, S.-O. 2019. A Chaperone Lid Ensures 
Efficient and Privileged Client Transfer during Tail-Anchored Protein Targeting. 
Cell Reports 26(1): 37-44.e7. doi: 10.1016/j.celrep.2018.12.035. 
 
 Molecular chaperones play key roles in maintaining cellular proteostasis. In 
addition to preventing client aggregation, chaperones often relay substrates within a 
network while preventing off-pathway chaperones from accessing the substrate. Here 
we show that a conserved lid motif lining the substrate-binding groove of the Get3 
ATPase enables these important functions during the targeted delivery of tail-
anchored membrane proteins (TAs) to the endoplasmic reticulum. The lid prevents 
promiscuous TA handoff to off-pathway chaperones, and more importantly, it 
cooperates with the Get4/5 scaffolding complex to enable rapid and privileged TA 
transfer from the upstream co-chaperone Sgt2 to Get3. These findings provide a 
molecular mechanism by which chaperones maintain the pathway specificity of 
client proteins in the crowded cytosolic environment. 
3.1 INTRODUCTION 
Protein homeostasis requires the proper folding, assembly, and localization 
of proteins inside a cell. Molecular chaperones play key roles in maintaining protein 
homeostasis by protecting their client proteins from off-pathway interactions and 
guiding the folding or localization of client proteins (Kim et al. 2013). Newly 
synthesized membrane proteins, which comprise up to 30% of the proteins encoded 
in the genome, are particularly challenging clients for chaperones due to the high 
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aggregation propensity of hydrophobic transmembrane domains (TMDs) in the 
cytosol, where membrane proteins are initially synthesized. In addition, TMDs are 
often degenerate in sequence, amino acid composition, and secondary structure 
propensity, making them susceptible to promiscuous interactions with off-pathway 
chaperones. Therefore, chaperones that engage integral membrane proteins not only 
need to effectively capture and shield client proteins from solvent, but also ensure 
that substrates remain on-pathway en route to the target membrane. Although recent 
advances defined the substrate binding domains and client interactions for a variety 
of membrane protein chaperones (Burmann et al. 2013, Huang et al. 2016, Liang et 
al. 2016, Thoma et al., 2015), how these chaperones ensure the pathway specificity 
of substrates remains poorly understood. 
Here we address this question in the conserved Guided Entry of Tail-
anchored protein (GET) pathway, which mediates the targeted delivery of tail-
anchored membrane proteins (TAs) to the endoplasmic reticulum (ER) in eukaryotic 
cells (Figure 3.1) (see Chapter 1). At the center of this pathway is the ATPase Get3 
(or mammalian TRC40) (Stefanovic and Hegde, 2007), which captures TAs from the 
upstream co-chaperone Sgt2 (or mammalian SGTA) (Wang et al. 2010). The Sgt2-
to-Get3 TA transfer is facilitated by ATP and the scaffolding complex Get4/5, which 
together pre-organize Get3 into a closed and ATPase-inhibited conformation optimal 
for TA capture (Gristick et al. 2014, 2015, Rome et al. 2013).  TA loading induces 
rapid opening motions in Get3 and activates ATP hydrolysis (see Chapter 2; Rome 
et al. 2013), which drives Get3 to switch its interaction partner from Get4/5 to the 
Get1/2 receptors at the ER membrane (see Chapter 2; Schuldiner et al. 2005, 2008). 
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Figure 3.1: Current model of the GET pathway in yeast. Newly synthesized TAs 
from the ribosome are first captured and chaperoned by Ssa1 and then delivered to 
the co-chaperone Sgt2 (step 1). Sgt2 next delivers the TA to the ATPase Get3 (step 
2), which in the cytosol is ATP-loaded and bound to a scaffolding complex Get4/5 
that also interacts with Sgt2. ATP and Get4/5 pre-organize Get3 in a closed 
conformation, and Get4/5 further inhibits Get3’s ATPase activity to prime Get3 for 
TA capture. TA loading onto Get3 induces Get3 to sample more open conformations 
that drives Get4/5 dissociation and activates Get3 to hydrolyze ATP (step 3). The 
resulting Get3•TA complex is in a strained conformation primed to interact with the 
Get1/2 membrane receptors (step 4). Get1/2 disassembles the Get3•TA complex and 
facilitates TA insertion into the ER (step 5), leaving Get3 bound to Get1 in an open 
conformation. ATP and Get4/5 help release Get3 from Get1 and recycle Get3 for 
further rounds of targeting (step 6). 
65 
 
The TA-TMD docks into a hydrophobic groove formed by ATP- and Get4/5-
bound Get3 (Mateja et al. 2009, 2015). Moreover, the transfer of TA from SGTA to 
TRC40 was not perturbed by excess calmodulin (CaM), an external chaperone (Shao 
and Hegde, 2011) that also binds TAs, indicating that TAs are protected from off-
pathway chaperones during their transfer (Shao et al. 2017). Nevertheless, as 
hydrophobic interactions are short-ranged, it is unclear how TAs are loaded into the 
deep TMD-binding groove of Get3, nor how they are shielded from solvent and 
external chaperones during and after loading. Intriguingly, a conserved helix 8 (α8; 
Figure 3.2) lines the substrate-binding groove of Get3 (Mateja et al. 2009, 2015). 
Although α8 is unresolved in most Get3 structures (Figure 3.2B) (Gristick et al. 2014, 
2015, Hu et al. 2009, Mateja et al. 2009, 2015), it can be crosslinked to TAs (Mateja 
et al. 2015). Mutation of conserved α8 residues resulted in yeast growth defects under 
stress conditions (Mateja et al. 2009) and impaired Get3-dependent TA targeting in 
yeast lysate (Rome et al. 2013). It was hypothesized that α8 acts as a dynamic lid to 
enclose the TA binding groove and prevent TAs from aggregation (Mateja et al. 
2015). In other chaperones or targeting factors, such as Hsp70 (Mayer and Bukau, 
2005) and the signal recognition particle (Akopian et al. 2013), a lid motif lining the 
substrate binding groove could also stabilize substrate binding or mediate substrate-
induced conformational changes. 
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Figure 3.2: A conserved α8 motif lines the substrate binding groove of Get3. (A) 
Sequence alignment of α8 and its flanking sequences among Get3 homologues. The 
mutations introduced in Get3(Δα8) are also shown (underlined). Hydrophobic 
residues are highlighted in green. ‘.’ and ‘:’ denote residues that are modestly or 
highly conserved in amino acid characteristic, respectively, and ‘*’ denotes residues 
that are highly conserved in identity. (B) The α8 motif and adjacent residues are 
highlighted (cyan) in the crystal structures of Get3 in the open (left; PDB 3H84) and 
closed (right; PDB 4XTR) conformations. Only one α8 motif is resolved in the open 
structure, while neither α8 motifs are not resolved in the closed structure. The 
question mark (“?”) denotes the uncertainty of the positioning of the α8 motifs. 
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Here, quantitative biochemical and biophysical analyses revealed unexpected 
roles of α8 in Get3 function. We found that although α8 is not necessary for 
maintaining a stable Get3•TA complex, it nevertheless prevents TA loss from Get3 
to off-pathway chaperones. Most importantly, α8 acts synergistically with Get4/5 to 
enable rapid TA transfer from Sgt2 to Get3 in a highly protected manner. We propose 
that α8 forms a molecular conduit for TA transfer to Get3, illustrating a mechanism 
that chaperones use to ensure client-pathway specificity in a crowded cytosolic 
environment. 
3.2 RESULTS 
α8 is necessary for efficient TA targeting 
 Previously, it was shown that mutation of conserved α8 residues (M200D and 
L201D) resulted in yeast growth defects under stress conditions, which is 
characteristic of defects in the GET pathway (Mateja et al. 2009). Different mutations 
of α8 also impaired Get3-dependent TA targeting to different extents in yeast lysate 
(Rome et al. 2013). To unambiguously assess the role of α8, we engineered a Get3 
mutant in which the highly conserved hydrophobic residues in α8 were replaced by 
a glycine-serine linker (Figure 3.2A, Get3(Δα8)) (see Chapter 2, Figure 2.14). Four 
lines of evidence show that the Δα8 mutation did not cause nonspecific structural 
defects in Get3. First, purified Get3(Δα8) migrated as a well-defined, homogeneous 
peak on size-exclusion chromatography similarly to wild-type Get3 (Figures 3.3A 
and 3.3B). Second, Get3(Δα8) adopted the same global fold as wild-type Get3 as 
determined by circular dichroism (Figure 3.3C). Third, Get3(Δα8) hydrolyzed ATP 
at rates similar to those of wild-type Get3 (Figure 3.3D). Fourth, Get3(Δα8) displayed 
ATP-dependent high affinity binding to Get4/5 similar to wild-type Get3 (Figures 
3.3E and 3.3F). Finally, Get3(Δα8) displayed a similar conformational distribution 
and underwent conformational regulations by nucleotides, Get1, and Get4/5 similarly 
to wild-type Get3 (Figure 3.4), as determined by a previously established single-
molecule FRET assay for monitoring global Get3 conformations (see Chapter 2). 
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Figure 3.3: Get3(Δα8) exhibits the same global structure, basal ATPase activity, 
and ATP-dependent binding to Get4/5 as wild-type Get3. (A and B) Size-
exclusion chromatogram of purified wild-type Get3 (A) and mutant Get3(Δα8) (B). 
The green and purple lines denote A280 and A260, respectively. (C) Circular dichroism 
spectra of 5 µM Get3(WT) (black) and 5 µM Get3(Δα8) (red). (D) Multi-turnover 
ATPase rate constants were determined with 0.5 µM mutant Get3(Δα8). The line was 
a fit of the data to Equation 3.9, which gave KM and kcat values of 2.2 ± 0.2 µM and 
0.30 ± 0.02 min-1, respectively. These values are within 2-fold to those previously 
reported for wild-type Get3 (KM = 3.6 ± 1.0 µM and kcat = 0.33 ± 0.03 min
-1 at 0.5 
µM Get3) (Rome et al. 2013). (E and F) Deletion of α8 does not affect the binding of 
Get4/5 to Get3, nor the allosteric regulation of Get3 by ATP for Get4/5 binding. 
Equilibrium titrations were carried out to measure the binding of Get4/5 to wild-type 
(black) and mutant Get3(Δα8) (blue) in the apo (E) and ATP-bound (F) states. 0.5 
µM of acrylodan-labeled Get4/5 was used in all experiments, and 2 mM ATP was 
present in experiments in (F). The lines are fits of the data to Equation 3.10, and gave 
Kd values of 3.8 ± 0.2 µM and 4.8 ± 3 µM for apo-Get3(WT) and Get3(Δα8), 
respectively, and 0.020 ± 0.008 µM and 0.015 ± 0.0003 µM for ATP-loaded 
Get3(WT) and Get3(Δα8), respectively. Values are reported as mean ± SD, with n = 
2. 
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Figure 3.4: Get3(Δα8) displays a similar conformational distribution and 
undergoes conformational regulations by nucleotides, Get1, and Get4/5 
similarly to wild-type Get3. (A) Approximate positions of donor and acceptor dyes 
(green and red stars, respectively) on Get3 in the open (left; PDB 3H84) and closed 
(right; PDB 2WOJ) conformations. The estimated distances between the dye pair are 
~75 Å in the open conformation and ~30 Å in the closed conformation. The Förster 
radius of the Cy3B-ATTO 647N dye pair used in this work is ~55 Å. The 
approximate positions of α8 that were not resolved in the structures are highlighted 
as cyan circles in the bottom panels. (B–F) FRET histograms illustrating 
conformational distributions for Get3(Δα8) in the apo (A), ADP-bound (B), 
AMPPNP-bound (C), Get1CD-bound (D), and Get4/5 and ADP-bound (E) states. 
The FRET histogram of Get3(Δα8) under each condition (grey bars) was similar to 
those displayed by wild-type Get3 (black lines, see Chapter 2, Figures 2.4 and 2.12). 
Importantly, Get3(Δα8) was specifically closed upon binding of AMPPNP (C) or 
binding with Get4/5 in the presence of ADP (E), and was opened by binding of 
Get1CD (D). 
We first measured the ability of purified Get3(Δα8) to target and translocate 
in vitro translated TAs into yeast rough microsomes (yRMs) in a Δget3 yeast lysate 
(Rome et al. 2013, Wang et al. 2010), assessed by glycosylation of an engineered 
opsin tag on the model TA upon successful insertion into the ER. Get3(Δα8) 
exhibited a strong defect in this reconstituted targeting reaction (Figure 3.5A), 
indicating that α8 is necessary for Get3 function. To test if Get3(Δα8) compromised 
TA targeting in vivo, we replaced genomic GET3 in S. cerevisiae with GET3-FLAG 
or GET3(Δα8)-FLAG and measured Get3 function in vivo using two independent 
assays. First, we measured the secretion of Kar2p, which is retained in the ER by 
retrograde trafficking in wild-type cells but is secreted into media from Δget3 cells 
due to defective biogenesis of SNARE proteins (a large class of TAs) (Schuldiner et 
al. 2005, 2008). GET3(Δα8)-FLAG yeast displayed increased levels of Kar2p 
secretion compared to Get3-FLAG yeast, consistent with compromised GET 
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pathway function (Figure 3.5B). Second, pulse-chase experiments showed that the 
insertion of a newly-synthesized model TA, BirA-Bos1-opsin (Cho and Shan, 2018), 
into the ER was significantly impaired in GET3(Δα8)-FLAG compared to GET3-
FLAG cells (Figure 3.5C). The defects of GET3(Δα8)-FLAG cells cannot be 
explained by a lower expression level of Get3(Δα8)-FLAG than Get3-FLAG (Figure 
3.5D).  These results indicate that the α8 element is also necessary for GET-
dependent targeting in vivo. 
 
Figure 3.5: The α8 motif in Get3 is important for TA targeting to the ER. (A) 
TA targeting and translocation by wild-type Get3 or mutant Get3(Δα8) in the Δget3 
yeast lysate. 10 µL translation reactions for the model TA Bos1 were carried out in 
Δget3 lysate in the presence of 10 µCi [35S]-methionine and purified Get3 or 
Get3(Δα8) at indicated concentrations. After 30 min at 26°C, cyclohexamide was 
added to stop translation. Δget3 microsomes were added where indicated, and the 
reactions were incubated for 40 min at 26°C and quenched by SDS sample buffer. 
Samples were analyzed by SDS-PAGE and autoradiography. Insertion efficiency 
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was calculated using Equation 3.2. (B) Kar2p secretion by GET3-FLAG, 
GET3(Δα8)-FLAG, and Δget3 yeast cells, measured as described (Schuldiner et al. 
2005). Yeast cultures were grown to saturation in YPD at 30°C overnight and diluted 
to an OD600 of 0.1 in fresh YPD. Cultures were grown at 30 °C to mid-log phase 
(OD600 ~ 1) and harvested. Cells were resuspended in fresh YPD to an OD600 of 0.5 
and incubated at 30 °C for 2 hours. Cells were harvested, and proteins from 1.35 mL 
of the supernatant (media) was precipitated by 10% TCA, washed with acetone, 
resuspended in 35 µL of SDS sample buffer, and neutralized by titrating 1M Tris-
HCl pH 9.5. Samples were analyzed by Western blot using an anti-Kar2p antibody 
(gift from P. Walter) at 1:3000 dilution. IRDye® 800CW Goat anti-Rabbit secondary 
antibody (LI-COR Biosciences) at 1:20,000 dilution was used for visualization using 
an Odyssey infrared imaging system. The top panel shows a representative western 
blot. The bottom panel shows quantification of the relative amount of secreted Kar2p 
from three biological replicates. Values are reported as mean ± SD. (C) Pulse-chase 
analysis to monitor the translocation of newly synthesized TA in vivo, carried out as 
described in Chapter 3.4 (Cho and Shan, 2018). Insertion into the ER results in 
glycosylation of the opsin tag on the TA, which allows untranslocated TA and 
glycosylated TA (TA-glyc) to be resolved on SDS-PAGE (top panel). The bottom 
panel shows the quantification of three independent experiments. The values 
represent mean ± SD (3 biological replicates). Error bars are shown but may be too 
small to be visible. (D) Clarified lysates of the cells from the same cultures in (B) 
were diluted with SDS sample buffer and immunoblotted against an anti-FLAG 
antibody (GenScript; top) to determine the steady-state Get3 levels in the different 
yeast strains. An anti-PGK1 (Abcam) blot served as a control for normalization 
(bottom). IRDye® 800CW Goat anti-Mouse secondary antibody (LI-COR 
Biosciences) was used for visualization using an Odyssey imaging system. 
Get3(Δα8)-FLAG is slightly overexpressed in GET3(Δα8)-FLAG cells compared to 
GET3-FLAG cells. 
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α8 shields TAs from off-pathway chaperones 
 To test whether α8 helps maintain a stable Get3•TA complex, we measured 
the kinetic stability of the Get3(Δα8)•TA complex using a FRET assay based on a 
donor dye incorporated near the TA-TMD and an acceptor dye labeled on Get3 near 
the substrate binding groove (Rao et al. 2016). We chased a preformed, purified 
Get3•TA complex with unrelated chaperones that can also effectively bind TAs and 
monitored TA release from Get3 as a loss of FRET (Figure 3.6A) (see Chapter 2, 
Figure 2.11). We used two independent chase molecules: a superactive variant of 
cpSRP43, a membrane protein chaperone in the chloroplast of green plants (Jaru-
Ampornpan et al. 2010, Schuenemann et al. 1998) and was shown to bind TAs (Cho 
and Shan, 2018) (Figures 3.6B and 3.7); and CaM, another TA-binding protein 
unrelated to the GET pathway (Shao and Hegde, 2011, Shao et al. 2017) (Figure 
3.6D). When the observed dissociation kinetics were extrapolated to zero chase 
concentrations to obtain the intrinsic Get3•TA dissociation rate constants (kdissociation; 
Figures 3.6C and 3.6E), wild-type Get3•TA and mutant Get3(Δα8)•TA exhibited 
kdissociation values that are within 2-fold of one another (Figure 3.6F). Thus, α8 is not 
required to maintain a kinetically stable Get3•TA complex. 
 
75 
 
Figure 3.6: α8 prevents promiscuous TA handoff from Get3 to off-pathway 
chaperones. (A) Schematic for measurement of Get3•TA dissociation kinetics. TA 
was labeled with a donor dye (cyan star), and Get3 was labeled with acceptor dyes 
(red stars). Addition of a chase drives irreversible Get3•TA dissociation, which can 
be monitored as a loss of FRET over time. (B), (D) Time courses for change in the 
fluorescence of TACM to monitor TA loss from Get3(Δα8) (50 nM initial complex) 
using indicated concentrations of intein-cpSRP43 (B) or CaM (D) as chase. 
Fluorescence was normalized such that the fit of each trace starts at 0 and ends at 1. 
(C), (E) Increasing concentrations of intein-cpSRP43 (C) or CaM (E) accelerated the 
observed rate of TA loss from Get3(Δα8), but not from wild-type Get3. (F) Summary 
of the dissociation rate constants for Get3•TA and Get3(Δα8)•TA complexes (0.0044 
± 0.0006 and 0.0026 ± 0.0004 min-1, respectively). Error bars denote SD, with n = 2-
3. 
 
Figure 3.7: cpSRP43 can bind TA proteins. (A) Fluorescence emission spectra 
were recorded using an excitation wavelength of 370 nm and an emission wavelength 
of 450 nm 40 hours after 50 nM wild-type Get3BDP•TACm was chased with indicated 
concentrations of cpSRP43. (B) The TACm fluorescence change at equilibrium based 
on the data in (A) was plotted against cpSRP43 concentration. The data was fit to 
Equation 3.6, which gave a K1/2,app value of 21 ± 0.7 µM in the presence of 50 nM 
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Get3. This suggests that TA is bound to Get3 by ~400-fold more strongly than to 
cpSRP43. 
During these measurements, we noticed that the observed kinetics of TA loss 
from Get3(Δα8) was strongly accelerated by increasing chase concentration (Figure 
3.6B–E), regardless of whether cpSRP43 or CaM was used as the chase. This kinetic 
behavior cannot be explained by a model in which the chase molecules acted as an 
inert TA-trap that simply binds dissociated TAs and prevents their rebinding to 
Get3(Δα8), as the observed reaction kinetics would be rate-limited by TA 
dissociation and independent of chase concentration in this model (Figures 3.8 and 
3.9). Rather, this observation indicates that external chaperones actively stimulate 
TA release from Get3(Δα8) (Figure 3.8B, top pathway). In contrast to Get3(Δα8), 
the observed TA release kinetics of wild-type Get3 was independent of chase 
concentration (Figure 3.6C) (see Chapter 2, Figure 2.11), indicating that the external 
chaperones act solely as passive TA-traps for wild-type Get3. Thus, although α8 is 
unnecessary for maintaining a stable Get3•TA complex, it helps Get3 to protect its 
bound substrate from access by and loss to other chaperones. 
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Figure 3.8: Kinetic simulations of TA release from Get3(Δα8). (A) Kinetic 
simulations (right) based on the passive model (left schematic), in which TA is first 
released from Get3(Δα8) before binding the chase. (B) Kinetic simulations (right) 
based on the active model (left schematic), in which Get3(Δα8) can directly handoff 
TAs to the chase molecule (upper pathway). Spontaneous TA dissociation from Get3 
and binding by the chase (lower pathway) was included in the model for completion. 
 
78 
 
Figure 3.9: Additional kinetic simulations of TA release from Get3(Δα8). (A–D) 
Changes in Get3•TA dissociation and association kinetics do not qualitatively affect 
the conclusion that the passive model cannot explain the experimentally observed 
rate dependence on chase concentration in Figure 3.6B. (E–F) Changes in the rate 
constants of cpSRP43•TA association and dissociation (the Kd value for 
cpSRP43•TA was held constant) do not affect the kinetic simulations for both the 
passive (E) and active (F) models. 
α8 and Get4/5 synergistically enable rapid and privileged TA transfer from Sgt2 to 
Get3 
 The results above and from previous work (Chapter 2) showed that the 
Get3(Δα8)•TA complex displays high kinetic stability. Moreover, purified 
Get3(Δα8)•TA was insertion-competent (see Chapter 2, Figure 2.10). We further 
showed that Get3(Δα8)•TA can mediate TA targeting and insertion into yRMs with 
the same efficiency as wild-type Get3 even with Get4/5 present (Figure 3.10), 
indicating that the Δα8 mutation does not disrupt TA-induced conformational 
changes that allows Get3 to exchange its binding partner from Get4/5 to the Get1/2 
receptors (Figure 3.1, steps 3-4) (see Chapter 2). These observations contrast with 
the strong defect of Get3(Δα8) in mediating TA targeting in yeast lysate and in vivo 
(Figure 3.5). Although Get3(Δα8) has a higher tendency to hand off the TA to 
external chaperones than wild-type Get3, the rate of TA loss from Get3(Δα8) (k ≥ 
0.015 min-1) is slow compared to that of TA insertion (k = 0.14 min-1; Figure 3.10) 
and unlikely to account for the observed targeting defect of this mutant. As the 
experiments in yeast lysate and in vivo include all the molecular steps in the GET 
pathway, we hypothesized that Get3(Δα8) has additional defects in steps prior to the 
formation of the Get3•TA complex. 
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Figure 3.10: TA targeting and insertion assays starting with preformed 
Get3•TA and Get3(Δα8)•TA complexes. All reactions contained 0.5 μM Get4/5 
and 2 mM ATP. Get3(Δα8) can still undergo TA-induced conformational changes to 
dissociate from Get4/5 to mediate membrane targeting (compare to mutants in 
Chapter 2, Figure 2.18B). 
The only major upstream step involving Get3 is the transfer of TA from Sgt2 
to Get3. To test if α8 is important for this transfer event, we used an established 
FRET-based assay (Rao et al. 2016) in which acceptor-labeled Get3 is presented to 
a preformed Sgt2•TA complex in which the TA is labeled with a donor dye (Figure 
3.11A). Successful TA transfer and loading onto Get3 give rise to efficient FRET 
between the dye pair (Rao et al. 2016). While we observed rapid TA transfer from 
Sgt2 to wild-type Get3 in the presence of Get4/5 (see also (Rao et al. 2016)), TA 
transfer to Get3(Δα8) under the same conditions was ~100-fold slower (Figure 
3.11B). Therefore, α8 plays an important role in ensuring rapid TA transfer from Sgt2 
to Get3. 
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Figure 3.11: α8 and Get4/5 synergistically enable rapid TA transfer from Sgt2 
to Get3. (A) Schematic of the FRET assay to measure TA transfer from Sgt2 to Get3. 
The cyan and red stars denote the donor and acceptor fluorophores on TA and Get3, 
respectively. (B, C) Donor fluorescence time courses of TA transfer from Sgt2 (25 
nM initial Sgt2•TA complex) to 0.3 µM Get3 or Get3(Δα8) with 75 nM Get4/5 
present (B), and to 3 µM Get3 or Get3(Δα8) without Get4/5 present (C). 
Fluorescence was normalized such that the fit of each trace starts at 1 and ends at 0. 
(D) Summary of observed TA transfer rate constants from the data in (B) and (C). 
Values are reported as mean (SD), with n = 2. Note that the Get4/5-independent TA 
transfer was measured at a 10-fold higher Get3 concentration than the Get4/5-
dependent transfer (indicated by ‘*’), such that the reported ratios are lower limits for 
the stimulatory effect of Get4/5 (indicated by ‘**’). 
Since the Get4/5 complex also stimulates TA transfer from Sgt2 to Get3 
(Mateja et al. 2015, Rao et al. 2016, Wang et al. 2010), we asked whether Get4/5 and 
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α8 work synergistically or independently of one another. We therefore measured and 
compared the rate of TA transfer from Sgt2 to Get3 and Get3(Δα8) without Get4/5 
present. Without Get4/5, deletion of α8 has a less deleterious effect, slowing TA 
transfer kinetics 12-fold (Figures 3.11C and 3.11D). Reciprocally, Get4/5 exerts a 
smaller stimulatory effect on the Sgt2-to-Get3 TA transfer with mutant Get3(Δα8) 
compared to wild-type Get3 (Figure 3.11D, last row). In control experiments, 
Get3(Δα8) binds Get4/5 and undergoes Get4/5-induced conformational changes 
similarly to wild-type Get3 (Figures 3.3E-F and 3.4), ruling out the possibility that 
the defect of Get3(Δα8) in Get4/5-dependent TA transfer is due to its defective 
binding or regulation by Get4/5. Together, these results show that α8 and Get4/5 
synergistically enhance TA transfer from Sgt2 to Get3. 
 Previously, it was shown that TA transfer from SGTA to TRC40, the 
respective mammalian homologs of Sgt2 and Get3, was impervious to the presence 
of excess CaM (Shao et al. 2017). We asked if α8 is important for maintaining this 
‘privileged’ transfer. To this end, we repeated the FRET-based TA transfer assay in 
the presence of excess CaM (Figure 3.12). TA transfer from Sgt2 to wild-type 
Get3•Get4/5 was not affected by excess CaM (Figure 3.12B), consistent with 
observations with their mammalian homologues. In contrast, the presence of CaM 
completely abolished FRET between TA and Get3 in transfer reactions without 
Get4/5 present (Figure 3.12C), or with mutant Get3(Δα8) even in the presence of 
Get4/5 (Figure 3.12D). Thus, TA transfer to Get3 becomes susceptible to interference 
by external chaperones in the absence of either Get4/5 or the α8 motif. 
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Figure 3.12: Both α8 and Get4/5 are required for privileged TA transfer to Get3 
in the GET pathway. (A) Schematic of the Sgt2-to-Get3 TA transfer assay in the 
presence of excess CaM. (B–D) In the fluorescence-based transfer assay, CaM did 
not affect TA transfer from Sgt2 to wild-type Get3•Get4/5 (B), but abolished the 
changes in donor fluorescence during Get4/5-independent TA transfer from Sgt2 (C) 
or during transfer from Sgt2 to Get3(Δα8)•Get4/5 (D). Where indicated, reactions 
contained 25 nM Sgt2•TA, 0.3 µM Get3 or Get3(Δα8), 75 nM Get4/5, and 20 µM 
CaM. 
 To independently test this model, we monitored the Sgt2-to-Get3 TA transfer 
using a crosslinking assay. Instead of a fluorescent dye, the photocrosslinker p-
benzoyl-l-phenylalanine (Bpa) was incorporated into the TA-TMD via amber 
suppression (Young et al. 2010). UV-induced crosslinking to Bpa allows direct 
visualization of the interaction of TA with different chaperones via SDS-PAGE and 
autoradiography (Figure 3.13A). In the absence of Get3, TA was rapidly lost from 
Sgt2 and transferred to CaM (Figure 3.13C), as was observed with the SGTA•TA 
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complex (Shao et al. 2017). Addition of Get3•Get4/5 resulted in rapid transfer of TA 
to Get3 without any TA loss to CaM (Figure 3.13B), consistent with observations for 
the homologous mammalian transfer complex (Shao et al. 2017) and with results of 
the FRET measurements (Figure 3.12B). In contrast, TA transfer to 
Get3(Δα8)•Get4/5 was almost completely abolished by the presence of CaM, and 
most of the TA crosslinked to CaM instead (Figure 3.13D). Together, the FRET and 
crosslinking experiments demonstrate that the α8 motif plays an essential role in 
enabling privileged TA transfer between Sgt2 and Get3. 
 
Figure 3.13: Independent verification that α8 is required for privileged TA 
transfer to Get3 in the GET pathway. (A) SDS-PAGE gel showing TA(Bpa) and 
its crosslink to different chaperones. ‘*’ denotes a minor crosslinked species in the 
presence of Sgt2 that was not interpreted. (B–D) Representative SDS-PAGE-
autoradiography analyses of the time courses of TA(Bpa) transfer from Sgt2 to 20 
µM CaM (C), and to 0.75 µM Get3•Get4/5 (B) or 0.75 µM Get3(Δα8)•Get4/5 (D) 
with or without 20 µM CaM present. ‘*’, ‘**’, and ‘***’ denote minor crosslinked 
species that were not interpreted. 
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 Lastly, we tested whether the role of α8 in the Sgt2-to-Get3 TA transfer 
explains the defect of Get3(Δα8) in the overall targeting reaction (Figure 3.5A). To 
this end, we initiated TA targeting by mixing a preformed Sgt2•TA complex with 
Get3, Get4/5, and yRM (Figure 3.14), such that the observed insertion reaction 
includes the TA transfer step. Addition of wild-type Get3 led to robust TA insertion 
within 5 min, whereas negligible insertion was observed with Get3(Δα8) (Figure 
3.14). This contrasts with the absence of a targeting defect with the preformed 
Get3(Δα8) complex (Figure 3.10) and indicates that the defect of Get3(Δα8) can be 
attributed to the loss of efficient TA transfer from Sgt2 to Get3. 
 
Figure 3.14: TA targeting and insertion assays starting with a preformed 
Sgt2•TA complex. Values indicate the quantified insertion efficiencies from the 
representative gel and replicates and are reported as mean ± SD, with n = 3. 
3.3 DISCUSSION 
Molecular chaperones play key roles in membrane protein biogenesis. While 
guiding client proteins to the target membrane, these chaperones must effectively 
secure hydrophobic TMDs on client proteins to prevent both aggregation and client 
loss to off-pathway chaperones. These challenges are especially acute for pathways 
in which client proteins undergo molecular handovers between chaperones. In this 
work, biochemical and biophysical analyses shed light on how a conserved α8 lid 
motif lining the substrate binding groove enables the Get3 ATPase to fulfill these 
requirements during TA targeting to the ER.  
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The importance of the α8 element is supported by its evolutionary 
conservation among Get3 homologues (Figure 3.2) (Mateja et al. 2009, Suloway et 
al. 2009), yeast growth defects under stress conditions upon mutation of α8 (Mateja 
et al. 2009), and the defects of mutant Get3(Δα8) in TA targeting in vitro and in vivo 
(this work). However, the precise roles of α8 remained enigmatic. Mechanistic 
dissections in this work show that the major roles of α8 are to accelerate TA transfer 
to Get3 from the upstream co-chaperone Sgt2 and to confer upon Get3 the privilege 
to receive TAs over competing chaperones. Deletion of hydrophobic residues in α8 
slowed Get4/5-dependent TA transfer from Sgt2 to Get3 by ~100-fold (Figures 
3.11B and 3.11E). Moreover, Get3 lost its privilege in capturing TAs from Sgt2 upon 
mutation of α8, and the TA substrate can be rapidly lost to an external chaperone 
(Figures 3.12 and 3.13). This explains the previous observation that mutations in α8 
reduced the amount of Get3-bound TAs in pulldown assays in rabbit reticulocyte 
lysate (Mateja et al. 2009). The cooperative effects of Get4/5 and α8 in promoting 
rapid and privileged TA transfer further suggest that they both stabilize the transition 
state or a transient intermediate during the transfer reaction. Coupled with the 
observation that α8 can crosslink to the TA (Mateja et al. 2015), the simplest model 
to explain all the data is that α8 provides the first structural element in Get3 to contact 
the TA during its handover from Sgt2, guiding the TA into the hydrophobic substrate 
binding groove of Get3 and protecting the TA from off-pathway chaperones during 
this process (Figure 3.15, bracket). 
Once the TA is loaded onto Get3, deletion of α8 also renders the TA more 
susceptible to challenges by external TMD-binding chaperones (Figure 3.15). 
Whether TAs could be analogously lost from Get3(Δα8) to other chaperones in the 
yeast cytosol remains to be determined. Nevertheless, the observation here that two 
unrelated membrane protein chaperones, cpSRP43 and CaM, can both invade the TA 
binding groove and capture TAs from Get3(Δα8) suggest that loss of substrates to 
off-pathway chaperones presents a probable mechanistic challenge during membrane 
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protein biogenesis, and that some chaperones such as Get3 have evolved mechanisms 
to actively retain substrates within the dedicated targeting pathway. 
 
Figure 3.15: Model for the dual roles of α8 as a substrate conduit and as a 
chaperone lid in the GET pathway. Upon interaction of Sgt2•TA with ATP- and 
Get4/5-bound Get3 (step 1), Get4/5 and the α8 element on Get3 cooperate to enable 
the formation of a transient transfer intermediate that provides a protected path for 
TA handover from Sgt2 to Get3. α8 mediates initial contacts with the TA and guides 
it into the substrate-binding groove on Get3, while also preventing external 
chaperones from accessing the substrate during the transfer (species in bracket). 
Get4/5 increases the local concentrations of Sgt2 and Get3 to enable the action of the 
α8 element. TA loading then induces conformational changes in Get3 that drive its 
dissociation from Get4/5 and stimulate ATP hydrolysis (step 3). Once the Get3•TA 
complex is formed and en route to the ER, α8 also acts as a lid to prevent substrate 
loss to off-pathway chaperones. 
The role of the α8 lid motif in facilitating rapid and privileged TA loading 
onto the chaperone is unprecedented, and highlights new mechanistic challenges as 
well as solutions for molecular chaperones. A dual-function lid described here 
provides an effective and elegant mechanism for a chaperone to capture and retain 
client proteins within the correct biogenesis pathway during and after substrate 
handover. This function may be particularly relevant for chaperones that interact with 
client proteins via degenerate interactions and face competition from other 
chaperones in the crowded cytosolic environment. 
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3.4 MATERIALS AND METHODS 
 S. cerevisiae strain construction 
 Genomic GET3 in the BY4741 strain was replaced with GET3-FLAG and 
GET3(Δα8)-FLAG using CRISPR-Cas9 mediated genome editing (Ryan et al. 2016). 
The pCAS plasmid encoding S. pyogenes Cas9 and sgRNA was modified to encode 
a guide sequence (5’-GAATATAACCCTATTACTGA-3’) that targets Cas9 to cut 
the codon for Get3(T342). This pCAS plasmid was co-transformed into BY4741 
yeast cells with a double-stranded linear repair DNA, which encodes Get3-FLAG 
harboring synonymous codon substitutions within the guide sequence and 50 bp 
homology downstream of the C-terminal FLAG tag for homologous recombination. 
The GET3(Δα8)-FLAG strain was then generated using a modified pCAS plasmid 
encoding a guide sequence (5’-GTTGTAGAAATCTTAATGTG-3’) that targets 
Cas9 to cut the codon for Get3(T173). The modified pCAS was co-transformed with 
a double-stranded linear repair DNA that encodes Get3(Δα8)-FLAG with 
synonymous codon substitutions within the guide sequence into GET3-FLAG yeast 
cells. Following each co-transformation, colonies from the YPD+G418 plate were 
cultured in YPD, streaked onto YPD, and cultured again in YPD to ensure loss of the 
pCAS plasmid. The final strains were verified by PCR and sequencing. 
Plasmids and recombinant proteins 
All plasmids and recombinant proteins used in this study are listed in Tables 
3.1 and 3.2. All proteins and protein complexes were ultracentrifuged (TLA100, 
Beckman Coulter Inc.) at 100,000 rpm for 30 min at 4°C to remove potential 
aggregates prior to use in in vitro assays. 
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Table 3.1: List of plasmids used in this study. 
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Table 3.2: List of recombinant proteins used in this study. 
Protein labeling 
Get3 and Get3(Δα8) with a ybbR tag (DSLEFIASKLA) inserted between 
residues S110 and D111 were labeled with BODIPY-FL (Thermo Fisher Scientific) 
or a 1:1 mix of Cy3B (GE Healthcare) and ATTO 647N (ATTO-TEC) via Sfp-
catalyzed incorporation of dye-CoA conjugates (Rao et al. 2016). 30 µM ybbR-Get3 
was mixed with 60 µM dye-CoA and 12 µM Sfp-His6 in Sfp labeling buffer (50 mM 
K-HEPES (pH 7.4), 10 mM MgCl2) in a total volume of 800 µL. The reaction mixture 
was rotated at room temperature for 1 hr. 10 µL 2 M imidazole (pH 8.0) was added 
before passing the reaction through Ni-NTA agarose (Qiagen) to remove Sfp-His6. 
Gel filtration through a Sephadex G-25 (Sigma-Aldrich) column was used to remove 
excess dye-CoA and exchange dye-labeled Get3 into GET storage buffer (50 mM K-
HEPES (pH 7.5), 150 mM KOAc, 5 mM Mg(OAc)2, 20% glycerol, 1 mM DTT). 
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Get4(C177T/S48C)/5 was labeled with thiol-reactive acrylodan (Thermo 
Fisher Scientific) (Rome et al. 2014). Protein was dialyzed into labeling buffer (50 
mM K-HEPES (pH 7.4), 200 mM NaCl, 10% glycerol) and treated with 2 mM TCEP 
to reduce disulfide bonds. A 10-fold excess of acrylodan was added and the reaction 
was incubated overnight at 4°C. The reaction was quenched with 1 mM DTT and 
excess dye was removed using a Sephadex G-25 column while exchanging 
acrylodan-labeled Get4/5 into GET storage buffer. 
TA substrate was labeled either four residues upstream of the TMD with 7-
hydroxycoumarin or replacing Ala 228 in Bos1 TMD with p-benzoyl-l-
phenylalanine (Bpa) using amber suppression in E. coli S30 lysate (Rao et al. 2016, 
Young et al. 2010). 
Model TA substrates 
The model TA used in all in vitro assays was the previously described 
3xStrep-SUMOnc-Bos1-opsin (Rao et al. 2016), composed of three tandem Strep 
tags at the N-terminus, a mutant yeast Smt3 with the Ulp1 cut site removed (Pro 
inserted between residues G98 and A99), the C-terminal residues 207-244 of the TA 
Bos1 encompassing its TMD, and an opsin tag at the extreme C-terminus 
(GSMRMNGTEGPNMYMPMSNKTVD) to monitor ER translocation via 
glycosylation. The model TA for in vivo pulse chase experiments was 3xHA-BirA-
Bos1TMD-opsin (Cho and Shan, 2018), composed of an N-terminal 3xHA-BirA for 
HA immunoprecipitation, the C-terminal residues 203-244 of the TA Bos1 
encompassing its TMD, a GS linker (GSGGSGS), and an opsin tag at the extreme C-
terminus. 
Get3•TA and Sgt2•TA complex preparation 
For fluorescence measurements, Get3BDP•TACM complexes were generated 
by in vitro translating 3xStrep-tagged TACM for 2 hrs at 30°C in 10 mL amber 
suppression reactions with E. coli S30 lysate in the presence of 0.5 µM BODIPY-
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FL-labeled Get3 variants. For insertion assays, 3xStrep-tagged TA was in vitro 
translated for 2 hrs at 30℃ in a 100 µL reaction with E. coli S30 lysate in the presence 
of 2 µM Get3 variants. The resulting Get3•TA complexes were then purified using 
Strep-Tactin Sepharose (IBA Life Sciences). 
Sgt2•TA complexes for transfer and insertion assays were generated by in 
vitro translation of TACM, TA(Bpa), or TA for 2 hrs at 30°C in 10 mL or 100 µL 
amber suppression reactions with E. coli S30 lysate in the presence of 1 µM His6-
tagged Sgt2. The Sgt2•TA complex was then purified using Ni-NTA (Qiagen). 
Fluorescence measurements of Get3•TA dissociation 
All fluorescence measurements were carried out on a Fluorolog 3-22 
spectrophotometer (HORIBA Instruments) at 25°C in GET assay buffer (50 mM K-
HEPES (pH 7.4), 150 mM KOAc, 5 mM Mg(OAc)2, 10% glycerol, 1 mM DTT). 
Get3•TA dissociation rates were measured by chasing 20-50 nM of 
preformed Get3BDP•TACM complexes with indicated concentrations of intein-
cpSRP43 or CaM. Loss of FRET over time was monitored by following the 
fluorescence of TACM using an excitation wavelength of 370 nm and emission 
wavelength of 450 nm.  Observed time courses were fit to Equation 3.1: 
𝐹 = 𝐹𝑒 + (𝐹0 − 𝐹𝑒)𝑒
−𝑘𝑜𝑏𝑠𝑑𝑡,            [3.1] 
where F is the observed donor fluorescence at a particular time, F0 is the donor 
fluorescence at t=0, Fe is the donor fluorescence when the reaction is complete, and 
kobsd is the observed rate constant of TA loss from Get3. 
Kinetic simulations of Get3•TA dissociation 
Kinetic simulations for the different models of Bos1-TA release from 
Get3(Δα8) were performed with Berkeley Madonna, version 8.3.18 (R. I. Macey, G. 
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F. Oster, University of California at Berkeley). For the passive model (Figure 3.8A), 
the following equations were used: 
 
For the active model (Figure 3.8B), the following chemical equations were used: 
 
The rate constant k1 was experimentally determined to be 0.0026 min
-1, or 4.3 x 10-5 
s-1 (Figure 3.6F). The Kd value of wild-type Get3•Bos1-TA was estimated to be 0.1 
nM based on the coupled equilibria of TA loading and transfer through the Ssa1-
Sgt2-Get3 cascade (Cho and Shan, 2018, Rao et al. 2016) shown in Equation 3.5: 
 
The Ssa1 concentration required for half-maximal solubilization of Bos1-TA (Kapp) 
was previously determined to be 0.37 ± 0.07 µM (Cho and Shan, 2018). Equilibrium 
titrations of Bos1-TA transfer from Ssa1 to Sgt2 indicated that this first transfer 
reaction is ~100-fold in favor of Sgt2 (Krel,1 ~ 100) (Cho and Shan, 2018). 
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Equilibrium titrations of Bos1-TA transfer from Sgt2 to Get3 suggested that this 
second transfer reaction is ~30-fold in favor of Get3 (Krel,2 ~ 30) (Rao et al. 2016). 
These data provide estimated Kd values of Sgt2•Bos1-TA and Get3•Bos1-TA of 
approximately 3.7 nM and 0.1 nM, respectively. This Kd and the measured k1 value 
yield a calculated k-1 of approximately 4.3 x 10
5 M-1s-1 for wild-type Get3•TA. Given 
the 100-fold slower ktransfer of Get3(Δα8) than wild-type Get3 (Figure 3.11), we 
estimated a 100-fold lower value of k-1, 4.3 x 10
3 M-1 s-1, for Bos1-TA binding to 
Get3(Δα8). Variations in the value of k-1 did not change the qualitative conclusion 
that the observed rate constant of Bos1-TA loss from Get3(Δα8) is independent of 
chase concentration in the passive model (Figures 3.9C and 3.9D). 
From chase experiments of wild-type Get3•Bos1-TA with cpSRP43, we 
found that a cpSRP43 concentration of 21 ± 0.7 µM was necessary for half-maximal 
Bos1-TA transfer in the presence of 50 nM Get3 after fitting the data in Figure S4B 
to 
𝐹 = 𝐹𝑚𝑎𝑥  ×  
[cpSRP43]
𝐾1/2,𝑎𝑝𝑝 + [cpSRP43]
   .        [3.6] 
This strongly suggests that intein-cpSRP43 binds TA with an ~400-fold weaker 
affinity than Get3. We estimated a Kd of ~40 nM for the cpSRP43-TA interaction. 
We assigned a lower limit for k2 of 1 x 10
5 M-1 s-1, given the observation that TA 
aggregation occurs within the mixing dead-time of ~15 s and that intein-cpSRP43 
effectively competes with TA aggregation (Cho and Shan, 2018). k-2 was calculated 
to be 0.004 s-1 from the estimated Kd and k2 values.  Increasing the values of k2 and k-
2 (holding a constant Kd value) does not change the results of the simulation (Figures 
3.9E and 3.9F). 
Normalized fluorescence change is proportional to the loss of the 
Get3(Δα8)•Bos1-TA complex and was calculated as 
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𝐹 =  1 −
[Get3(Δα8) • TA]
[Get3(Δα8) • TA ]0
 ,          [3.7] 
where [Get3(Δα8)•TA]0 is the initial Get3(Δα8)•TA concentration and was set to 20 
nM. The rate constants k3 and k-3 in Equation 3.4 were determined to be 1.54 x 10
3 
M-1 min-1 and 5.11 x 10-4 min-1, respectively, by allowing the software to fit the 
simulated time courses to the experimental results. The obtained value of k3 was equal 
to that obtained from manual fitting of the data in Figure 3.6B, which was also 1.54 
x 103 M-1 min-1. 
Monitoring TA transfer from Sgt2 to Get3 
TACM transfer from Sgt2 to Get3BDP was monitored by mixing 120 µL of ~50 
nM Sgt2• TACM with 120 µL of a solution containing 0.6 µM or 6 µM Get3BDP. 2 
mM ATP was present in all reactions. Where indicated, transfer reactions also 
contained 0.15 µM Get4/5 with and without 40 µM CaM (supplemented with 1 mM 
Ca2+). To correct for photobleaching and possible environmental effects on the donor 
fluorophore, transfer reactions to unlabeled Get3 were also performed in parallel 
under the same conditions. Time courses of fluorescence changes were recorded for 
TACM, corrected for photobleaching and possible environmental effects, and fit to 
Equation 3.1, where kobsd is the observed rate constant for TA transfer from Sgt2 to 
Get3. 
To monitor TA transfer from Sgt2 to Get3 via crosslinking, Sgt2•TA(Bpa), 
containing 300 nM Sgt2 and sub-stoichiometric levels of [35S]-methionine-labeled 
TA(Bpa), was added to 750 nM Get3 and 750 nM Get4/5. Where indicated, CaM 
was present at 20 µM. All reactions contained 2 mM ATP, 1 mM Ca2+ and were 
incubated at 26°C. At indicated time points, aliquots were removed from the reaction, 
flash frozen, and subsequently crosslinked on dry ice ~4 cm away from a UVP B-
100AP lamp (UVP LLC) for 90 minutes. Aliquots were then thawed and processed 
for SDS-PAGE and autoradiography. 
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TA targeting assays 
To monitor TA targeting and translocation from preformed Get3•TA or 
Get3(Δα8)•TA complexes, 50 µL reactions were initiated by adding 10 µL Δget3 
microsomes to purified Get3•TA complexes in the presence of 0.5 µM Get4/5 and 2 
mM ATP. [35S]-methionine-labeled TA was normalized to 40,000 dpm for each 
reaction. Reactions were incubated at 26°C; at indicated time points, 6 µL samples 
were removed and quenched by addition of SDS sample buffer and flash-freezing in 
liquid nitrogen. Samples were analyzed by SDS-PAGE and autoradiography. 
Insertion efficiencies were calculated using Equation 3.8:  
𝐼𝑛𝑠𝑒𝑟𝑡𝑖𝑜𝑛 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 =  
𝐼𝑔𝑙𝑦𝑐𝑜𝑠𝑦𝑙𝑎𝑡𝑒𝑑
𝐼𝑢𝑛𝑔𝑙𝑦𝑐𝑜𝑠𝑦𝑙𝑎𝑡𝑒𝑑 + 𝐼𝑔𝑙𝑦𝑐𝑜𝑠𝑦𝑙𝑎𝑡𝑒𝑑
 × 100,           [3.8] 
where I denotes the intensity of the band of interest. 
TA targeting and insertion assays starting with a preformed Sgt2•TA 
complex were measured using purified Sgt2•TA complexes, in which TA is 35S-
methionine labeled and normalized to 40,000 dpm. Sgt2•TA was first mixed with 
other components except for microsomes to 8 µL, and then after 15s, 2 µL Δget3 
microsomes were added to initiate reactions. Reactions contained 75 nM Get4/5, 2 
mM ATP, 0.5 µM wild-type Get3 or Get3(Δα8), and 20 µM cpSRP43 where 
indicated. Initiated reactions were incubated at 26°C for 5 minutes before quenching 
with SDS sample buffer and flash freezing with liquid nitrogen. Samples were 
analyzed by SDS-PAGE and autoradiography. Insertion efficiencies were calculated 
using Equation 3.8. 
Pulse-chase analysis of TA insertion in vivo 
GET3-FLAG, GET3(Δα8)-FLAG, and Δget3 yeast cells were first 
transformed with a pRS316 vector containing a GPD promoter and the 3xHA-BirA-
Bos1TMD-opsin TA substrate (Cho and Shan, 2018). Transformed yeast cells were 
96 
 
grown in SD-Ura to mid-log phase (OD600 ~ 0.6), washed with SD-Ura-Met-Cys 
media, and resuspended in 1 mL SD-Ura-Met-Cys media to a final OD600 of 6. Cells 
were incubated at 30°C for 25 min and then incubated at 26°C for an additional 10 
min. Cells were pulse-labeled with 100 μCi/mL EasyTag™ EXPRESS35S Protein 
Labeling Mix (Perkin Elmer) for 2 min and chased with 1 mL SD-Ura supplemented 
with 20 mM cold methionine and 2 mM cysteine. 450 µL aliquots of cells were flash 
frozen in liquid nitrogen at indicated times during chase. Individual cell aliquots were 
subsequently thawed and harvested.  
Cells were treated with 0.3 M NaOH for 3 min at room temperature, washed 
with water, resuspended in Lysis buffer (20 mM Tris-HCl (pH 7.6), 150 mM NaCl, 
2% SDS), incubated at 70°C for 10 min, and then spun down at 14,000 rpm (16,873 
g) for 2 min. Clarified lysate was diluted over 20-fold with HA IP buffer (20 mM 
Tris-HCl (pH 7.6), 150 mM NaCl, 1% Triton X-100) and incubated with anti-HA 
magnetic beads (Thermo Fisher Scientific) equilibrated with HA IP buffer containing 
0.4 mg/mL BSA.  After incubation at 25°C for 10 min, the beads were sequentially 
washed with: W1 buffer (20 mM Tris-HCl (pH 7.6), 150 mM NaCl, 1% Triton X-
100, 2M urea), W2 buffer (20 mM Tris-HCl (pH 7.6), 500 mM NaCl, 1% Triton X-
100), W3 buffer (20 mM Tris-HCl (pH 7.6), 150 mM NaCl, 0.1% SDS), and W4 
buffer (20 mM Tris-HCl (pH 7.6), 150 mM NaCl). The final wash with W4 buffer 
was performed twice. Immunoprecipitated proteins were eluted with SDS sample 
buffer, boiled for 5 min, and analyzed by SDS-PAGE and autoradiography. Insertion 
efficiencies were calculated using Equation 3.8. 
Circular dichroism 
Circular dichroism spectra of wild-type Get3 or Get3(Δα8) at 5 µM in 20 mM 
sodium phosphate pH 7.5 were recorded using an Aviv Model 430 circular dichroism 
spectrometer at 25 °C. For each sample, 8 scans from 190 nm to 260 nm were 
collected, averaged, and background subtracted.  
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ATPase measurements 
Multi-site, multi-turnover ATPase rate constants were measured for 0.5 µM 
Get3(Δα8) and indicated ATP concentrations in GET assay buffer at 25°C (Rome et 
al. 2013). The ATP concentration dependence of observed rate constants were fit to 
an allosteric sigmoidal curve with a Hill coefficient of 2 (Equation 3.9): 
𝑘𝑜𝑏𝑠𝑑 =  
𝑘𝑐𝑎𝑡  ×  [𝐴𝑇𝑃]
2
𝐾𝑀
2 + [𝐴𝑇𝑃]2
 ,         [3.9] 
where kcat is the rate constant at saturating ATP concentrations, and KM
2 is the product 
of ATP binding affinities for the first and second active site. 
Measurements of Get3-Get4/5 binding 
Equilibrium binding affinities between Get3 variants and acrylodan-labeled 
Get4/5 were measured by titrating 250 µL of 0.5 µM acrylodan-labeled Get4/5 with 
increasing Get3 concentration in the absence (Figure 3.3E) or presence (Figure 3.3F) 
of 2 mM ATP. Binding of Get3 results in fluorescence enhancement of acrylodan-
labeled Get4/5 and was recorded using an excitation wavelength of 370 nm and 
emission wavelength of 490 nm. Fluorescence was plotted against Get3 
concentration and fit to Equation 3.10: 
𝐹 =  𝐹0 + 𝐹𝑚𝑎𝑥 
×  
𝐾𝑑 + [𝐺𝑒𝑡4/5] + [𝐺𝑒𝑡3] − √(𝐾𝑑 + [𝐺𝑒𝑡3] + [𝐺𝑒𝑡4/5])2 − 4[𝐺𝑒𝑡3][𝐺𝑒𝑡4/5]
2[𝐺𝑒𝑡4/5]
, [3.10] 
where F is the observed fluorescence, F0 is the initial fluorescence value, Fmax is the 
maximum fluorescence change at saturating Get3 concentration, and Kd is the 
equilibrium dissociation constant of the complex. 
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µs-ALEX measurements 
All proteins were ultracentrifuged in a TLA 100 rotor (Beckman Coulter) at 
100,000 rpm for 1 hr at 4℃ to remove aggregates before all measurements. Get3 
samples were diluted to ~100 pM in GET assay buffer containing 0.3 mg/mL BSA 
and indicated interaction partners. 2 mM AMPPNP, 4 mM ADP, 10 µM Get1CD, 
and 4 µM Get4/5 were included where indicated. Samples were placed in a closed 
chamber made by sandwiching a perforated silicone sheet (Grace Bio-Labs) with two 
coverslips to prevent evaporation. Data were collected over 30 min using an 
alternating-laser excitation fluorescence-aided molecule sorting setup (Kapanidis et 
al. 2004) with two single-photon Avalanche photodiodes (PerkinElmer) and 532-nm 
and 638-nm continuous wave lasers (Coherent) operating at 135 µW and 80 µW, 
respectively. 
Statistical parameters 
All statistical parameters (n and SD) for assays in this study are reported in 
the corresponding figure legends. 
µs-ALEX data analysis 
For the collected µs-ALEX data, a dual-channel burst search (Nir et al. 2006) 
was performed using FRETBursts (Ingargiola et al. 2016) to isolate the photon 
streams from species containing FRET pairs versus background noise and species 
containing donor or acceptor only. Each burst was identified as a minimum of 10 
consecutive detected photons with a photon count rate at least 15-fold higher than the 
background photon count rate during both donor and acceptor excitation periods. 
Since the background rate can fluctuate within a measurement, the background rate 
was computed for every 50 second interval according to maximum likelihood fitting 
of the interphoton delay distribution. The identified bursts were further selected 
according to the following criteria: (i) nDD + nDA ≥ 25 and (ii) nAA ≥25, where nDD is 
the number of photons detected from donor during donor excitation, nDA is the 
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number of photons detected from acceptor during donor excitation, and nAA is the 
number of photons detected from acceptor during acceptor excitation. 
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